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1. INTRODUCTION 
As the number of poorly soluble compounds coming out of drug discovery increases, 
conventional formulation strategies may no longer suffice in providing acceptable 
bioavailability and targeted clinical profiles. In modern molecular pharmaceutics, advanced 
delivery technologies, such as Lipid based drug delivery systems (LBDDS) become an 
essential approach in the development of new chemical entities. LBDDS are a group of 
technologies that utilize lipid molecules; alone or in combination with other biocompatible 
materials to present drugs in a more harmonious to the biological systems.  
Lipid based drug delivery systems are nowadays popular as they are expected to be 
the promising carriers because of their potential to increase solubility and improve 
bioavailability of poorly water soluble and/ or lipophilic drugs (Bharti Gaba et al., 2015).  
The most frequent role of lipid based formulations has traditionally been to improve 
the solubility of sparingly water soluble drugs especially Bio pharmaceutical classification 
system (BCS) classes II and IV drugs. However, the spectrum of applications for lipid based 
formulations has widened as the nature and type of active drugs under investigation vary. 
Lipid based formulations may also protect active compounds from biological degradation or 
transformation that in turn can lead to an enhancement of drug potency. In addition, lipid 
based particulate DDS have been shown to reduce the toxicity of various drugs by changing 
the bio distribution of the drug away from sensitive organs (Anthony A. Attama et al., 2012).  
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Fig 1: Biopharmaceutical classification system (BCS) 
1.1. Merits of LBDDS 
A well researched and commercially proven technology, lipid based formulations 
have seen shown to improve solubility and bioavailability. LBDDS include: lipid solutions, 
emulsions, self emulsifying systems (SMEDDS and SNEDDS), liposomes and solid lipid 
particles. These formulations provide greater bioavailability due to increased solubilisation of 
a compounds and increased surface area resulting in emulsification and micro- emulsification 
of the lipid formulation in the GI tract.  
Lipid drug delivery is also an attractive option for controlled drug release and targeted 
drug delivery. Using molecular assembly and coating technologies, formulations can be 
designed to tailor a desired release profile and target it to a specific area in the GIT. 
The introduction of advanced generation of lipid nanoparticles named as NLCs has 
overcome the general limitation associated with conventional lipid based formulations and 
solid lipid nanoparticles(SLNs). Earlier, SLN attracted lot of attention as a drug delivery 
system for they offer the advantages of biocompatibity, drug targeting, modified release and 
ease of large scale production. However, depending on the drug, various potential problems 
can occur, such as drug leaking during storage and insufficient drug loading. Later on, NLCs 
are designed by mixing the solid lipid with the liquid lipid, which leads to special 
nanostructures with improved properities for therapeutic loading, alteration of the drug 
• Low Solubility
• Low Permeability
• High Solubility
• Low Permeability
• Low Solubility
• High Permeability
• High Solubility
• High Permeability
Class 1 Class 2
Class 4Class 3
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release profile and stability. The major advantage of this type of carrier/ delivery system is its 
ability to incorporate large quantities of drugs as a result of formation of a less ordered lipid 
matrix with many imperfections. NLCs ensure close contact to the stratum corneum owing to 
its unique lipid composition and smaller particle size, thereby enhancing drug flux through 
the skin. Also, because of solidified lipid matrix, a controlled release of the therapeutic 
moiety from these carriers is possible. NLCs for the reason that they formed a less ordered 
lipid matrix with many imperfections have the ability to incorporate large quantities of drugs. 
They are also found to significantly increase skin hydration and exhibits occlusive properities 
due to reduction in the tranepidermal water loss (Jana Pardeike et al., 2009). 
Rapid advances in the ability to produce nanoparticles of uniform size, shape, and 
composition have started a revolution in science. The development of lipid-based drug 
carriers has attracted increased attention over the last decade. Lipid nanoparticles (e.g. solid 
lipid nanoparticles, SLNs) are at the forefront of the rapidly developing field of 
nanotechnology with several potential applications in drug delivery, clinical medicine and 
research, as well as in other varied sciences. Due to their size-dependent properties, lipid 
nanoparticles offer the possibility to develop new therapeutics that could be used for 
secondary and tertiary level of drug targeting. Hence, lipid nanoparticles hold great promise 
for reaching the goal of controlled and site specific drug delivery and have attracted wide 
attention of researchers. At the turn of the millennium, modifications of SLN, nanostructured 
lipid carriers (NLC) and lipid drug conjugate (LDC)-nanoparticles were introduced in 
addition to liquid crystal DDS. These carrier systems overcome observed limitations of 
conventional SLN and more fluid lipid DDS. Compared to liposomes and emulsions, solid 
particles possess some advantages, e.g. protection of incorporated active compounds against 
chemical degradation and more flexibility in modulating the release of the compound. This 
will focuses on the different lipid based nano systems, their structure and associated features, 
stability, production methods, drug incorporation and other issues related to their formulation 
and use in drug delivery (Anthony A. Attama et al., 2012). 
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The following advantages among others could be ascribed to lipid nanocarriers: 
 Ability to control and target drug release 
 Ability to improve stability of pharmaceuticals 
 Ability to encapsulate high drug content (Compared to other carrier systems 
e.g. Polymeric nanoparticles). 
 The feasibility of carrying both lipophilic and hydrophilic drugs 
 Most of the lipids used are bio degradable and as such they have excellent. 
 Biocompatibility are non toxic, non allergenic and non irritating 
 They can be formulated by water based technologies and thus can avoid 
organic solvents.  
 They are easy to scale up and sterile 
 They are less expensive than polymeric/ surfactant based carriers 
 They are easy to validate    
1.2. General routes of LBDDS 
Routes like oral, parentral, ocular, intranasal, dermal/ transdermal and vaginal can be 
for the administration of the lipid based drug delivery systems (LBDDS). However, oral route 
is the most preferred route because of the properities like non-invasiveness, less expensive 
and less side effects, such as injection-site reactions. It is also considered as the easiest and 
the most convenient method of drug delivery for chronic therapies. But, at a very early stage 
of development, formulation strategies based on a rational and systematic approach need to 
be developed to avoid erratic and poor in vitro/ in vivo correlations and thus increase the 
chances of success in formulation development. Various useful guidelines regarding routes 
and formulation strategies have been published by several authors (Hina Shrestha et al., 
2014).  
Points to be considered for the formulation 
Main factors affecting the choice of excipients for lipid based formulations are as follows:  
i. Solubility 
ii. Dispersion  
iii. Digestion  
iv. Absorption 
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Other factors are as follows: 
i. Regulatory issues-irritancy, toxicity, knowledge and experience. 
ii. Solvent capacity 
iii. Miscibility 
iv. Morphology at room temperature (i.e., melting point) 
v. Self- dispersibility and role in promising self- dispersion of the formulation. 
vi. Digestibility and fate of digested products 
vii. Capsule compatibility 
viii. Purity, chemical stability 
ix. Cost of goods (Hina Shrestha et al., 2014).  
1.3. LIPID DRUG DELIVERY SYSTEMS 
Lipid based DDS are an accepted, proven, commercially viable strategy to formulate 
pharmaceuticals for topical, oral, pulmonary or parentral delivery. Lipid formulations cab be 
tailored to meet a wide range of product requirements. One of the earliest lipid DDS 
liposomes have been used to improve solubility. Currently, some companies have established 
manufacturing processes for the preparation of large scale batches of sparingly soluble 
compounds, often at drug concentrations several orders of magnitude higher than the nominal 
aqeous solubility because of the introduction of novel lipid based DDS (Anthony A. Attama 
et al., 2012).  
1.4. TETRAHYDROCURCUMIN 
Tetrahydrocurcumin (THC), one of the major metabolites of curcumin, which has 
same physiological and pharmacological properties as that of curcumin. THC is insoluble in 
water and soluble in alcohol, acetone and glacial acetic acid. The pharmacological effect of 
THC is limited due to its low aqueous solubility. In addition, a relative short gastric emptying 
time can result in an incomplete release of THC from the dosage form at the site of 
absorption which cause diminished efficacy of the administered dose (Bharti Gaba et al., 
2015) 
The regular curcuminoids once ingested reach to intestine, where they need to pass 
through the absorption barrier to enter the biological system. Further the reductase system at 
the cellular level then converts the curcumin to tetra hydocurcumin. Tetrahydrocurcuminis an 
active metabolite of the curcumin as investigation in its activity reveals. 
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THC has been identified in the intestinal and hepatic cytosol from humans and rats. 
The reduction of curcumin to THC was proposed to occur via a reductase enzyme in the 
cytosolic compartment either in intestine or hepatic cells. THC has also been demonstrated 
that it has anti-cancer and anti-angiogenic effect and prevents type II diabetes. It was also 
proved that it is more effective than curcumin in preventing azoxymethane induced colon 
carcinogenesis. 
THC is categorized as BCS class IV drugs owing to its poor aqueous solubility and 
poor GI absorption. 
In the present context, development of nutricosmetics with natural preservation 
system will be beneficial for the broad application and development of nutricosmetics. The 
present investigation is focused on the  development and optimization of natural preservation 
system and development of nutricosmetic loaded with nano lipid carrier with nutraceutical.   
1.5. NUTRACEUTICALS 
Nutraceuticals can be defined as a food or part of a food that provides medical or 
health benefits including the prevention or treatment of a disease.  
When food is being cooked or prepared using “scientific intelligence” with or without 
knowledge of how or why it is being used, the food is called “functional food”. Thus, the 
functional food provides the body with the required amount of vitamins, fats, proteins, 
carbohydrates, etc, needed for its healthy survival.  
When functional food aids in the prevention or treatment of diseases or disorders 
other than anemia, it is called a nutraceuticals. Thus, a functional food for one consumers can 
act as a nutraceutical for another consumer. Examples of nutraceuticals include fortified dairy 
products (eg- milk) and citrus fruits (eg- orange juice). 
Several Criteria for nutraceuticals., 
 Is a product (other than tobacco) that is intented to supplement the diet that bears or 
contains one or more of the following dietary ingredients : a vitamin, a mineral, an 
herb or other botanicals, an amino acid, a dietary substancefor use by man to 
supplement the diet by increasing the total daily intake, or a concentrate, metabolite, 
constituents, extract, or combination of these ingredients.  
 Is intended for ingestion in pill, capsule, tablet or liquid form. 
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 Is not represented for use as a conventional food or as the sole item of a meal or diet.  
 Is labelled as a dietary supplement. 
Thus, nutraceuticals differ from dietary supplements in the following aspects: 
 nutraceuticals must not only supplement the diet but should also aid in the prevention 
and treatment of diseases.  
 Nutraceuticals are represented for use as a conventional food or as the sole item of 
meal or diet. 
1.6. TOPICAL DRUG DELIVERY SYSTEM 
Over the last decades the treatment of illness have been accomplished by 
administering drugs to human body via various roots namely oral, sublingual ,rectal ,parentral 
,topical ,inhalation etc.topical delivery can be defined as the application of a drug containing 
formulation to the skin to directly treat cutaneous disorder or the cutaneous manifestations of 
a general disease (eg:psoriasis) with the intent of containing the pharmacological or the effect 
of drug to the surface of the skin or within the skin semi-solid formulations in all their 
diversity dominate the system for topical delivery , but foams ,spray , medicated powders 
,solutions and even medicated adhesive systems ae in the use. (Kotta Kranthi Kumar et al. 
2011).  
Localized drug delivery by semi-solid dosage forms continues to be a major area of 
research.advances in formulation approache shave led to increased drug stability as well as 
improve ment in the aesthetic appeal of semisolid dosage forms (R.E. Ugandar et al. 2013).  
 One or more drug substances dissolved or dispersed in a suitable base,usually an oil 
in water  emulsion or aqueous microcrystalline dispersion of long- chain fatty acids or 
alcohols that are water washable and are cosmetically and aesthetically acceptable. Semisolid 
dosage forms for dermatological drug therapy are intended to produce desired therapeutic 
action at specific sites in epidermal tissue. A drug ability to penetrate the epidermis, dermis 
and  subcutaneous fat  layers of skin depends on the properties of drug and the carrier base 
although some drugs are meant primarily for surface action on the skin , the target area for 
most dermatological disorders lies in the viable epidermis or upper dermis.  
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1.7. COSMETICS  
“cosmetics are external preparation meant for apply on external part of the body i.e., 
nails, skin, hair for coloring, covering, softening, cleaning nourishing waving ,setting 
,mollification, preservation ,removal and  protection˝.we can also define it as “A cosmetic is 
an item intended  to be rubbed, poured, sprinkled or sprayed on, introduced  in to or 
otherwise applied to the human body or any part of there for cleansing, beautifying, 
promoting attractiveness or altering the appearance ˝ 
Throughout the recorded history of man, cosmetics have been used with essentially 
the same three goals in mind namely to enhance appeal through decoration of the body. To 
camouflage flaws in the integument and to alter or improve upon nature .consider several 
historical vignettes showing the role of cosmetics down through the ages. 
In daily life, human skin is exposed to variety of environmental factors and conditions 
that have detrimental effects on dermal integrity. The consequences are dry skin ,wrinkles 
,cracks and eventually sepsis. The most protective and preventive step taken against dry skin 
formation and related disorders is the use of emollients or moisturizing creams and lotions 
preferably with antiseptic properties. 
1.8. COSMETIC DELIVERY SYSTEM. 
Skin act as a selective barrier to the penetration of compounds, hence cosmetic 
products should be compatible o the skin barrier which is attainable by using  compatible 
carriers  emulsions, fluorocarbon gels, liposomes, cyclodextrins, microcapsules etc, which are 
stable and allow controlled & sustained release of actives and bioavailability enhancers.the 
penetration of active  compound through the skin is of fundamental importance in cosmetic 
science, to this end, the formulation of appropriate carriers is a must both for cosmetic and 
dietary supplements. 
Expectations from a cosmetic product  
While many age related changes are inevitable ,some can be reduced with healthy 
lifestyle and good skin care, free radical damage, inflammatory responses due to UV 
exposure ,pollution etc., are the main factors responsible for skin damage .cosmetics should 
help skin retain and enhance its natural form for a longer time by target specific mechanism 
of action  and perfect delivery system. 
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1.9. Cosmeceuticals  
Cosmeceuticals refer to the combination  of cosmetics and pharmaceuticals ,they 
contain biologically active ingredients that are known  to be beneficial to humans .the term 
cosmeceutical is used in the professional skin care arena to portray a product that has 
measurable biological accomplishment in the skin, like a drug, but is regulated as a cosmetic 
as a cosmetic  since it claims to have an effect on appearance and is used for the treatment of 
conditions ranging from photo aging ,wrinkles, hyper pigmentation  to hair damage. Their 
widespread use as products for skin, lips and nail care is also worth mentioning. Applying 
nanotechnology in the development of cosmeceuticals offers numerous advantages like 
targeting of the active therapeutic component to the desired site; Improvement in the stability 
of cosmetic ingredients ; greater aesthetic appearance and sustained release of active drug for 
long-lasting effect. Some of the nanotechnology-based novel carriers of cosmetics include 
nanoemulsion, nanocapsule, liposome, niosome, nanocrystal, solid lipid nanoparticle, carbon 
nanotube, fullerence and dendrimers. 
Cosmeceutical cream 
Cream consist of medicaments dissolved or suspended in water removable or 
emollient bases. Cream are classified as water-in-oil or oil-in-water therefore, combining 
immiscible compounds is possible by mechanical agitation or heat. The wet gum, dry gum, 
bottle, and  beaker method are employed, more recently. The term  has been  restricted to 
products consisting of  oil-in-water emulsions or aqueous microcrystalline dispersions of long 
chain fatty acids or alcohols that are water washable and more cosmetically and aesthetically 
acceptable. 
1.10. TYPES OF COSMECEUTICAL CREAM 
 
Most commonly available creams classified on the basis of their function. 
• Cleansing & cold cream or lotion 
• Vanishing & Foundation cream 
• Night & massage cream 
• Hand & body cream 
• All purpose cream 
• Moisturizing cream (Kotta Kranthi Kumar et al. 2011).  
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A cream is a topical preparation usually for application to the skin. Creams for 
application to mucous membranes such as those of the rectum or vagina are also used. 
Creams may be considered pharmaceutical products as even cosmetic creams are based on 
techniques developed by pharmacy and unmedicated creams are highly used in a variety of 
skin conditions (dermatoses). The use of the finger tip unit concept may be helpful in guiding 
how much topical cream is required to cover different areas. 
Creams are semi-solid emulsions of oil and water. They are divided into two types: 
oil-in-water (O/W) creams which are composed of small droplets of oil dispersed in a 
continuous phase, and water-in-oil (W/O) creams which are composed of small droplets of 
water dispersed in a continuous oily phase. Oil-in-water creams are more comfortable and 
cosmetically acceptable as they are less greasy and more easily washed off using water. 
Water-in-oil creams are more difficult to handle but many drugs which are incorporated into 
creams are hydrophobic and will be released more readily from a water-in-oil cream than an 
oil-in-water cream. Water-in-oil creams are also more moisturising as they provide an oily 
barrier which reduces water loss from the stratum corneum, the outermost layer of the skin. 
A base in which the pharmaceutical active ingredient is incorporated should be stable, 
non- irritating to the body, chemically and physiologically inert, compatible with a variety of 
drugs, stable during storage, without pharmacological activity or interfere with the release of 
drug substance and be able to provide products of esthetical value and easy to process during 
manufacturing. 
1.11. COMPOSITIONS IN PREPARATION OF CREAM 
There are four main ingredients of the cosmeceutical cream 
 Water 
 Oil 
 Emulsifier 
 Thickening agent 
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Advantages 
 Avoidance of first pass metabolism  
 Convenient and easy to apply 
 Avoid of risk 
 Inconveniences of intravenous therapy and the varied conditions of absorption like pH 
Changes presence of enzymes gastric emptying time etc., 
 Achievement of efficacy with lower total daily dosage of drug by continuous drug 
input 
 Avoid fluctuation of drug levels inter and intra patent variations 
Disadvantages 
 Skin irritation of contact dermatitis may occur due to the drug and excipients 
 Poor permeability of some drugs through the skin 
 Possibility of allergic reactions 
 Can be used only for drugs which require very small plasma concentration for action 
 Enzyme in epidermis may denature the drugs 
 Drugs of larger particle size not easy to absorb through the skin 
1.12. NUTRICOSMETICS 
The vital anti-aging synergy of cosmetics and nutricosmetics. Nutricosmetics 
stimulate cell mechanisms in the skin’s inner (the dermis) and help in its renewal. They also 
boost the skin’s natural defences. They provide it with nutrients from within, which 
strengthen the antioxidant defence system and improve skin hydration and the structural 
elements which both encourage cell regeneration and stimulate production of collagen, elastin 
and keratin… thus offering in depth protection against tissue damage.  
Anti-aging cosmetics essentially act on the skin’s outer layers (the epidermis) to improve its 
hydration, appearance and conditions. They contain ingredients which help restore hydration 
and stimulate collagen production on the skin’s surface and in its outer layers. They combat 
the signs of photo-aging, improve softness and firmness and gradually reduce reduce the most 
visible damage, fines lines and wrinkles. Nutricosmetics and cosmetics thus act in perfect 
synergy to delay the ravaging effects of time on the skin and restore its radiance and youthful 
appearance. 
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Specifically, Nutricosmetics are formulated to: 
 Increase ROS scavenging activity 
 Reduce chronic inflammation 
 Stimulate immunity 
 Support healthy skin cell renewal and strong dermal structure 
 Potencially repair photo- damaged skin 
 Promote healthy hair and nails 
 Support weight management 
Consumers are becoming more interested in “natural” alternatives to skin health and beauty. 
It is coincides with the ecofriendly and organic beauty brands. Nutricosmetics ingredients are 
often naturally sourced, making them appealing to this type of consumer, particular within 
the channels of distributions where this demographic resides. Technical ingredients or 
formulations may not work best within this sector.  
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2. REVIEW OF LITERATURE 
2.1. Nanotechnology  
Nanotechnology is considered to be the most prospective technology of the 21st 
century, and can be defined as the nano-scale formulation, characterization, and application 
of compositions, devices, and structures by domineering shape and size. This approach is 
being used to amend the penetration of the incorporated active components and is achieved 
by the variation of several aspects, for manipulating the release profile. The development of 
nanotechnology-based innovative formulations shows a good deal of potential for skin 
administration. In the present day, this escalating technology plays a significant role in rising 
above the traditional drawbacks related to cosmetics and allied products (Bangale Ms1 et al., 
2012).  
2.2. Solid Lipid Nanoparticle (SLN):  
SLNs were developed in the 1990s as an alternative carrier system to the existing 
traditional carriers, such as emulsions, liposomes and polymeric nanoparticles (Attama et al., 
2012). They are a comparatively stable colloidal carrier system in which melted lipid is 
dispersed in an aqueous surfactant by high-pressure homogeni-zation or micro-emulsification 
(Müller et al., 2000). They are generally made up of a solid hydrophobic core containing the 
drug dissolved or dispersed. SLNs exhibit certain potential advantages over polymeric nano-
particles. They are safely taken up by brain and exhibit the least toxicity due to the 
biodegradable nature of the carrier lipid (Mohammed et al., 2012; Blasi et al., 2007; Kaur et 
al., 2000). Smaller size (around 10 to 200 nm) and narrow size range (100 to 200 nm) allows 
them to cross tight endothelial cells of the blood-brain barrier, escape from the 
reticuloendothelial system (RES), and bypass the liver (Attama et al., 2012). They have 
comparatively higher drug entrapment efficiency, render the drug more stable in their lipid 
matrix, and provide a controlled release. Their production can be scaled up with excellent 
reproducibility. Surface coating of SLNs with hydrophilic polymers or surfactants, such as 
poly ethylene glycol (PEG) minimizes their uptake in liver cells and results in improved 
bioavailability (Salome Amarachi Chime* and Ikechukwu V. Onyishi, et al.,2013).  
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2.3. Nano Structured lipid carriers (NLC) 
NLC are colloidal carriers characterized by a solid lipid core consisting of a mixture 
of solid and liquid lipids, and having a mean particle size in the nanometer range (Attama et 
al., 2012). They consist of a lipid matrix with a special nanostructure (Attama et al., 2012; 
Ravani et al., 2013). This nanostructure improves drug loading and firmly retains the drug 
during storage. NLC system minimizes some problems associated with SLNs such as low 
payload for some drugs; drug expulsion on storage and high water content of SLNs 
dispersions. The conventional method for the production of NLC involves mixing of spatially 
very different lipid molecules, that is blending solid lipids with liquid lipids (oils). The 
resulting matrix of the lipid particles shows a melting point depression compared with the 
original solid lipid but the matrix is still solid at body temperature. Depending on the method 
of production and the composition of the lipid blend, different types of NLC are obtained 
(Attama et al., 2012). 
The suitability of Nano structured lipid carriers (NLCs) for the encapsulation of 
lipophilic drug was assessed for oral and topical administration. The hot high pressure 
homogenization (HPH) technique was used as production method for SLN. Mechanical 
approaches are capable of producing nanoparticles, typically in the 100–1000 nm range, 
whereas chemical methods tend to produce 10–100 nm particles.(A.C. Silva et al.,2011) 
2.4. FUNCTIONAL PROPERTIES OF LIPIDS USED IN FORMULATING LIPID 
DRUG DELIVERY SYSTEMS 
a) Crystallinity and polymorphism of lipids 
Many pharmaceutical solids exist in different physical forms. It is well recognised 
that drug substances and excipients can be amorphous, crystalline or anhydrous, at various 
degrees of hydration or solvated with other entrapped solvent molecules, as well as varying in 
crystal hardness, shape and size. Amorphous solids consist of disordered arrangements of 
molecules and do not possess a distinguishable crystal lattice. In the crystalline state 
(polymorphs, solvates/hydrates, co-crystals), the constituent molecules are arranged into a 
fixed repeating array built of unit cells, which is known as lattice. Possession of adequate 
crystallinity is a prerequisite for a good lipid particulate DDS. Triglycerides, which are 
mainly used as lipid matrices crystallize in different polymorphic forms. The most important 
forms are the α and β forms. Since the formulation of lipid particulate DDS may involve 
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melting at some point, recrystallization from the melt results in the metastable α-polymorph, 
which subsequently undergoes a polymorphic transition into the stable β-form via a 
metastable intermediate form (β'). The β-polymorph especially consists of a highly ordered, 
rigid structure with low loading capacity for drugs. The formation of all these polymorphic 
forms has been proved amongst solid triglyceride nanoparticles (Anthony A. Attama et al., 
2012). 
b) Melting characteristics of lipid matrices 
A pure triacylglycerol has a single melting point that occurs at a specific temperature. 
Nevertheless, certain lipids contain a wide variety of different triacylglycerols, with different 
melting points and as a result, they melt over a wide range of temperatures, producing a wide 
endothermic transition in differential scanning calorimeter. High purity lipids with sharp 
melting transitions exclude drugs on recrystallization. In addition to the solidity or melting 
point of each individual triglyceride, in drug delivery, we are interested and concerned with 
the combination of triglycerides throughout the fat mixture. This impacts the plasticity and 
the melting point range. In the development of lipid nanoparticles, lipids with melting points 
well above the body temperature are preferred. This will enable among others, sustained 
release of the encapsulated drug. 
c) Crystallinity and polymorphism vs drug loading capacity and drug release 
Crystallinity and polymorphism have a lot of influence on some properties of lipid 
matrices used in lipid DDS. Parameters like drug loading capacity and drug release depend 
highly on the crystallinity and the polymorphic form of the lipids. The crystalline order and 
density increase from α to β forms and are highest for the β-forms of polymorphic lipids. An 
increasing crystalline order has a great impact on the drug loading capacity, since an increase 
in order reduces the ability to incorporate different molecules including drugs. Hence, the 
drug loading capacity of the poorly organized polymorphic forms is high. 
However, this advantage goes along with the particles being in a metastable form which are 
able to transform into the stable β-polymorph upon storage. As a consequence of this 
transformation, often drug expulsion occurs. The increasing order of the matrix also reduces 
the diffusion rate of a drug molecule within the particle and hence reduces the rate of drug 
release. 
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2.5. STRATEGIES TO IMPROVE DRUG LOADING IN LIPID PARTICULATE 
DRUG DELIVERY SYSTEMS 
The high crystallinity of SLN leads to a rather low drug loading capacity for many 
drugs, a problem still being addressed. However, for lipophilic drugs the incorporation into 
the particles is much easier and often results in rather high drug loading. In order to overcome 
the disadvantage of low loading capacity, many investigations have been done. In these 
formulations, lipids of highly ordered crystalline structure are combined chemically different 
lipids of amorphous structure, giving rise to structure matrices that accommodate more drug. 
.Friedrich et al reported a different method to increase the drug payload by incorporating 
amphiphilic phospholipids into the lipid matrix. This resulted in a much higher solubility of 
the drug in the matrix, which was attributed to the formation of a solidified reverse micellar 
solution within the matrix. In this case, the nanoparticles were prepared by cold 
homogenization which may have prevented a redistribution of the lecithin to the surface of 
the particles or into the aqueous phase. Such behaviour could be observed for a similar 
system after high pressure homogenization of the molten lipids. Another mechanism of 
increasing the drug loading capacity of SLN has been recently developed. In these works, the 
researchers used mixtures of solid lipids of natural origin possessing fatty acids of different 
chain lengths. In the analytical characterization of the lipid mixtures using differential 
scanning calorimetry (DSC), X-ray diffraction and isothermal microcalorimetery, it was 
observed that the mixtures were able to form matrices of imperfect structure composed of 
mixed crystals and mixtures of crystals, which enhanced drug incorporation compared with 
the single lipids (Anthony A. Attama et al., 2012). 
2.6. INGREDIENTS USED IN THE FORMULATION OF LIPID BASED 
PARTICULATE DRUG DELIVERY SYSTEM 
Emulsifiers 
Emulsifiers are essential to stabilize lipid nanoparticle dispersions and prevent particle 
agglomerations. The choice of the ideal surfactant for a particular lipid matrix is based on the 
surfactant properities such as charge, molecular weight, chemical structure and respective 
hrdrophilic – lipophilic balance (HLB). The HLB of an emulsifier is given by the balance 
between the size and strength of the hydrophilic and the lipophilic groups. Table 1 shows 
some of the emulsifiers employed in the production of lipid nanoparticles. The choice of the 
emulsifiers depends on the route of administration of the formulation, for e.g. for parentral 
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formulations, there are  limits of the emulsifiers to be used. For topical and ocular route the 
issue of skin sensitization has to be considered, while for oral route, the emulsifier should not 
produce any physiological effect at the use concentration. Emulsifiers could be used in 
combination to produce synergistic effect and better  stabilize the formulation (Anthony A. 
Attama et al., 2012). 
     Table 1. Some emulsifiers used for the production of lipid nanoparticles 
S.no Emulsifier/ Coemsulifier HLB 
1. Lecithin 4-9 
2. Poloxamer 188 29 
3. Poloxamer 407 21.5 
4. Polysorbate 20 16.7 
5. Polysorbate 65 10.5 
6. Polysorbate 85 15 
7. Cremophor EL 12-14 
8. Solutol HS 15 15 
 
LIPIDS 
The carboxylic acid group of a fatty acid molecule provides a convenient place for 
linking the fatty acid to an alcohol, via ester linkages. If the fatty acid becomes attached to an 
alcohol with a long carbon chain, the resultant substance is called a wax. When glycerol and a 
fatty acid molecule are combined, the fatty acid portion of the resultant compound is called 
an acyl group, and the glycerol portion is referred to as a glyceride. A triacylglyceride thus 
has three fatty acids attached to a single glycerol molecule. Sometimes, this name is 
shortened to triglyceride. Triglyceride substances are commonly referred to as fats or oils, 
depending on whether they are solid or liquid at room temperature. A lipid is thus a fatty or 
waxy organic compound that is readily soluble in non polar solvents (e.g. ether), but not in 
polar solvent (e.g. water). Examples of lipids are waxes, oils, sterols, cholesterol, fat soluble 
vitamins, monoglycerides, diglycerides (fat) and phospholipids. Fatty acids(including fats) 
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are a subgroup of lipids. Hence it will be inaccurate to consider the terms synonymous 
(Anthony A. Attama et al., 2012). 
Classification of solid lipids for delivery of bioactives 
Lipids can be grouped into the following categories based upon their chemical composition 
Homolipids 
Homolipids are esters of fatty acids with alcohols. They are lipids containing only 
carbon (C), hydrogen (H) and oxygen (O), and as such are referred to as simple lipids. The 
principal materials of interest for oral delivery vehicle are long chain and medium chain fatty 
acids linked to a glycerol molecule known as triacylglycerols. The long chain fatty acids 
ranging from C14 to C24 appear widely in common fat while the medium chain fatty acids 
ranging from C6 to C12 are typical components of coconut oil or palm kernel oil. Examples 
of homolipids include: cerides (waxes e.g. beeswax, carnauba wax etc), glycerides (e.g. fats 
and oils) and sterides (e.g. the esters of cholesterol with fatty acids).  
Heterolipids 
Heterolipids are lipids containing nitrogen (N) and phosphorous (P) atoms in addition 
to the usual C, H and O e.g. Phospholipids, glycolipids and sulfolipids. They are also known 
as compound lipids. The emphasis here will be on the phospholipids only. Two main classes 
of phospholipids occur naturally in qualities sufficient for pharmaceuticals applications. 
There are the phosphoglycerides and phosphosphingolipids such as ceramide are used mainly 
in topically dosage forms. Phospholipids can be obtained from all types of biomass because 
they are essential structural components in all kinds of membranes of living organisms. 
Complex lipids 
The more complex lipids occur closely linked with proteins in cell membranes and 
subcellular particles. More active tissues generally have higher complex lipid content. They 
may also contain phospholipids. Complex lipids in this context include lipoproteins, 
chylomicrons, etc. lipoproteins are spherical lipid protein complexex that are responsible for 
the transport of cholesterol and other their within the body. Structurally, lipoprotein consists 
of an a polar core composed of cholesterol esters or triacylglycerols, surrounded by 
monolayer of phospholipid in which cholesterol and one or more specific apoproteins are 
embedded e.g. chylomicrons and lipoproteins.  
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Bilayer lipids used in drug delivery 
Some lipids are capable of adopting a certain orientation depending on the processing 
condition. Compounds that have approximately equal-sized heads and tails e.g. phospholipids 
tend to form bilayers instead of micelles associate tail to tail, thus minimizing the contact of 
the hydrophobic portion with water and maximizing hydrophilic interaction. The 
phospholipid molecules can move about in their half the bilayer, but there is a significant 
energy barrier preventing migration to the other side of the bilayer. 
Non-bilyer lipids used in drug delivery 
In many biological systems, the major lipids are non-bilayer lipids, which in purified 
form cannot be arranged in a lamellar structure in the presence of aqueous systems. The 
structural and functional roles of these lipids in drug delivery are mainly in their utilization as 
matrix-forming lipids. They include such lipids as homolipids e.g. triglycerides and waxes. 
Their functional properties in lipids nanotechnology differ depending partly on their melting 
points, crystallinity and polymorphic characteristics. However they may have absorption 
promoting properties especially for liphophilc drugs. Table 2 shows some of the non-bilayer 
lipids used in the formulation of lipids micro- and nanoparticles. 
Table 2. Some non-bilayer lipids used in the formulation of lipid nanoparticles 
Hard fats e.g. Natural Hard fats e.g. 
Stearic acid 
Palmitic acid 
Behenic acid 
 
Goat fat 
Theobroma oil 
Triglycerides e.g. Waxes e.g. 
Trimyristin (Dynasan 114) 
Tripalmitin (Dynasan 116) 
Tristearin   (Dynasan 118) 
Trilaurin 
 
Bees wax 
Cetyl palmitate 
Carnauba wax 
Mono, di and triglycerides mixtures e.g. 
Witepsol bases 
Glyceryl monostearate (Imwitor 900) 
Glyceryl behenate (Compritol 888 ATO) 
Glyceryl palmitostearate (Precirol ATO 5) 
Softisan 142 and softisan 154 
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2.7. Lipid nanoparticulate drug delivery systems 
Lipid nanoparticles show interesting nanoscale properties necessary for therapeutic 
application. Lipid nanoparticles are attractive for medical purposes due to their important and 
unique features, such as their surface to mass ratio that is much larger than that of other 
colloidal particles and their ability to bind or adsorb and carry other compounds. Lipid nano 
formulations produce fine dispersions of poorly water soluble drugs and can reduce the 
inherent limitations of slow and incomplete dissolution of poorly water soluble drugs (e.g. 
BCS II & IV drugs), and facilitate formation of solubilised phases from which drug 
absorption occurs. In any vehicle mediated delivery system (whether the vehicle is an 
emulsion, liposome, noisome or other lipidic systems), the rate and mode of drug release 
from the system is important in relation to the movement of the delivery system in vivo 
(Anthony A. Attama et al., 2012). 
Lipid particulate DDS abound depending on their architecture and particle size. Due 
to the large number of administration routes available, these delivery systems perform 
differently depending on the formulation type and route of administration. Figure 2 shows 
some of the different lipid nanoparticulate drug delivery system available. 
 
Fig 2: Different lipid nanoparticulate Drug delivery system 
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Solid lipid nanoparticles (SLN) 
SLN are particulates structurally related to polymeric nanoparticles. However, in 
contrast to polymeric systems, SLN can be composed of biocompatible lipids that are 
physiologically well tolerated when administered in vivo and may also be prepared without 
organic solvents. The lipid matrices can be composed of fats or waxes (homolipids) that 
provide protection to the incorporated bioactive from chemical and physical degradation, in 
addition to modification of drug release profile. Typical formulations utilize lipids such as 
paraffin wax or biodegradable glycerides (e.g. Compritol 888 ATO) as the structural base of 
the particle. 
SLN were developed in the 1990s as an alternative carrier system to the existing 
traditional carriers, such as emulsions, liposomes and polymeric nanoparticles. SLN are 
prepared either with physiological lipids or lipids with generally regarded as safe (GRAS) 
status. Under optimized conditions they can incorporate lipophilic or hydrophilic drugs and 
seem to fulfil the requirements for an optimum particulate carrier system. SLN have a 
potential wide application spectrum- parenteral administration and brain delivery, ocular 
delivery, rectal delivery, oral delivery, topical delivery and vaccine delivery systems etc., in 
addition to improved bioavailability, protection of sensitive drug molecules from the outer 
environment and even controlled release characteristics. Common disadvantages of SLN are 
particle growth, unpredictable gelation tendency, unexpected dynamics of polymorphic 
transitions and inherent low incorporation rate due to the crystalline structure of the solid 
lipid. 
Nanostructured lipid carriers (NLCs) 
NLC are colloidal carriers characterized by a solid lipid core consisting of a mixture 
of solid and liquid lipids and having a mean particle size in the nanometer range. They 
consists of a lipid matrix with a special nanostructure. This nanostructure improves drug 
loading and firmly retains the drug during storage. NLC system minimizes some problems 
associated with SLN such as low payload for some drugs; drug expulsion on storage and high 
water content of SLN dispersions. The conventional method for the production of NLC 
involves mixing of spatially very different lipid molecules, i.e. blending solid lipids with 
liquid lipids (oils). The resulting matrix of the lipid particles shows a melting point 
depression compared with the original solid lipid but the matrix is still solid at body 
temperature. Depending on the method of production and the composition of the liquid blend, 
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different types of NLC are obtained. The basic idea is that by giving the giving the lipid 
matrix a certain  nanostructure, the payload for active compounds is increased and expulsion 
of the compound during storage is avoided. Ability to trigger and even control drug release 
should be considered while mixing lipids to produce NLC. Newer methods of generating 
NLC are being developed.  
Lipid drug conjugates (LDC)-nanoparticles 
A major problem of SLN is the low capacity to load hydrophilic drugs due to 
partitioning effects during the production process. Only highly potent low dose hydrophilic 
drugs may be suitably incorporated in the solid lipid matrix. In order to overcome this 
limitation, LDC nanoparticles with drug loading capacities of up to 33% were developed. An 
insoluble drug-lipid conjugate bulk is first prepared either by salt formation (e.g. with a fatty 
acid) or by covalent linking (e.g. to ester or ethers). The obtained LDC is then processed with 
an aqueous surfactant solution to nanoparticle formulation by high pressure homogenization 
(HPH). Such nanoparticles may have potential application in brain targeting of hydrophilic 
drugs in serious protozoal infections. 
Liposomes 
Liposomes are closed vesicular structures formed by bilayers of hydrated 
phospholipids. The bilayers are separated from one another by aqueous domains and enclose 
an aqueous core. As a consequence of this alternating hydrophilic and hydrophobic structure, 
liposomes have the capacity to entrap compounds of different solubilities. Additionally, the 
basic liposome structure of hydrated phospholipid bilayers is amenable to extensive 
modification or 'tailoring' with respect to the physical and chemical composition of the 
vesicle. This versatility has resulted in extensive investigation into the use of liposomes for 
various applications such as in radiology, cosmetology and vaccinology. Liposomes used in 
drug delivery typically range from 25 nm to several micrometers and are usually dispersed in 
an aqueous medium. There are various nomenclatures for defining liposome subtypes based 
either on structural parameters or the method of vesicle preparation. These classification 
systems are not particularly rigid and a variation exists in use the of these terms, particularly 
with respect to size ranges. Liposomes are oftendistinguished according to their number of 
lamellae and size. Small unilamellar vesicles (SUV), large unilamellar vesicles and large 
multilamellar vesicles or multivesicular vesicles are differentiated. SUVs with low particle 
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sizes in the nanometer range are of interest as liposomal nanocarriers for drug and antigen 
delivery. 
Transfersomes 
Transfersome technology was developed with the intention of providing a vehicle to 
allow delivery of bioactive molecules through the dermal barrier. Transfersomes are 
essentially ultra-deformable liposomes, composed of phospholipids and additional 'edge 
active' amphiphiles such as bile salts that enable extreme distortion of the vesicle shape. The 
vesicle diameter is in the order of 100 nm when dispersed in buffer. These flexible vesicles 
are thought to permeate intact through the intact dermis under the forces of the hydrostatic 
gradient that exists in the skin. Drug or antigen may be incorporated into these vesicles in a 
manner similar to liposomes. 
Niosomes 
Niosomes are vesicles composed mainly of non-ionic bilayer forming surfactants. 
They are structurally analogous to liposomes, but the synthetic surfactants used have 
advantages over phospholipids in that they are significantly less costly and have higher 
chemical stability than their naturally occurring phospholipid counterparts. Niosomes are 
obtained on hydration of synthetic non-ionic surfactants, with or without incorporation of 
cholesterol or other lipids. Niosomes are similar to liposomes in functionality and also 
increase the bioavailability of the drug and reduce the clearance like liposomes. Niosomes 
can also be used for targeted drug delivery, similar to liposomes. As with liposomes, the 
properties of the niosomes depend both on the composition of the bilayer and the method of 
production. Antigen and small molecules have also been delivered using niosomes. 
Liquid crystal drug delivery systems 
The spontaneous self assembly of some lipids to form liquid crystalline structures 
offers a potential new class of sustained release matrix. The nanostructured liquid crystalline 
materials are highly stable to dilution. This means that they can persist as a reservoir for slow 
drug release in excess fluids such as the gastrointestinal tract (GIT) or subcutaneous space, or 
be dispersed into nanoparticle form, while retaining the „parent' liquid crystalline structure. 
The rate of drug release is directly related to the nanostructure of the matrix. Lyotropic liquid 
crystal systems that commonly consist of amphiphilic molecules and solvents can be 
classified into lamellar (Lα), cubic, hexagonal mesophases, etc. In recent years, lyotropic 
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liquid crystal systems have received considerable attention because of their excellent 
potential as drug delivery vehicles. Among these systems, reversed cubic (QII) and hexagonal 
mesophases (HII) are the most important and have been extensively investigated for their 
ability to sustain the release of a wide range of bioactives from low molecular weight drugs to 
proteins, peptides and nucleic acids. 
Nanoemulsions 
Lipid-based formulations present a large range of optional delivery systems such as 
solutions, suspensions, self-emulsifying systems and nanoemulsions. Among these 
approaches, oral nanoemulsions offer a very good alternative because nanoemulsions can 
improve the bioavailability by increasing the solubility of hydrophobic drugs and are now 
widely used for the administration of BCS class II and class IV drugs. Oral nanoemulsions 
use safe edible materials (e.g., food-grade oils and GRAS-grade excipients) for formulation 
of the delivery system. Nanoemulsions possess outstanding ability to encapsulate active 
compounds due to their small droplet size and high kinetic stability. Nanoemulsions have 
sizes below 1 μm and have been extensively investigated as novel lipid based DDS together 
with microemulsions. 
2.8. PREPARATION OF LIPID NANOPARTICULATE DRUG DELIVERY 
SYSTEMS 
There many methods for the preparation of lipid nanoparticulate DDS. The method 
used is dictated by the type of drug especially its solubility and stability, the lipid matrix, 
route of administration, etc. Liposomal preparation follows a different method as described 
by Mozafari. In this section, emphasis was laid on the production of SLN, NLC and LDC 
nanoparticles, with methods that can also be applied to the formulation of liquid crystal DDS 
(Anthony A. Attama et al., 2012). 
1. High pressure homogenization 
High pressure homogenisation (HPH) is a suitable method for the preparation of SLN, 
NLC and LDC-nanoparticles and can be performed at elevated temperature (hot HPH 
technique) or at and below room temperature (cold HPH technique). The particle size is 
decreased by impact, shear, cavitation and turbulence. Briefly, for the hot HPH, the lipid and 
drug are melted (approximately 10°C above the melting point of the lipid) and combined with 
an aqueous surfactant solution at the same temperature. A hot pre-emulsion is formed by 
homogenisation (e.g. using Ultra-Turrax). The hot pre-emulsion is then processed in a 
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temperature-controlled high pressure homogenizer at 500 bar (or more) and predetermined 
number of cycles. The obtained nanoemulsion recrystallizes upon cooling down to room 
temperature forming SLN, NLC or LDC-nanoparticles. The cold HPH is a suitable technique 
for processing heat-labile drugs or hydrophilic drugs. Here, lipid and drug are melted together 
and then rapidly ground under liquid nitrogen forming solid lipid microparticles. A pre-
suspension is formed by homogenisation of the particles in a cold surfactant solution. This 
pre-suspension is then further homogenised in a HPH at or below room temperature at 
predetermined homogenisation conditions to produce SLN, NLC or LDC-nanoparticles. The 
possibility of a significant increase in temperature during cold homogenisation should be 
borne in mind. Both HPH techniques are suitable for processing lipid concentrations of up to 
40% and generally yield very narrow particle size distributions. A schematic representation 
of HPH method of lipid particle preparation is shown in Figure 3. 
 
 
Fig 3: A schematic representation of HPH method of lipid particle preparation 
2. Production of SLN via microemulsions 
Gasco developed and optimised a suitable method for the preparation of SLN via 
microemulsions. In a typical process, a warm microemulsion is prepared and thereafter, 
dispersed under stirring in excess cold water (typical ratio about 1:50) using a specially 
developed thermostated syringe. The excess water is removed either by ultra-filtration or by 
lyophilisation in order to increase the particle concentration. Experimental process 
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parameters such as microemulsion composition, dispersing device, effect of temperature and 
lyophilisation on size and structure of the obtained SLN should be optimized. The removal of 
excess water from the prepared SLN dispersion is a difficult task with regard to the particle 
size. Also, high concentrations of surfactants and cosurfactants (e.g. butanol) are necessary 
for the formulation, but less desirable with respect to regulatory purposes and application. 
3. SLN prepared by solvent emulsification/evaporation 
For the production of nanoparticle dispersions by solvent emulsification/evaporation, 
the lipophilic material is dissolved in water immiscible organic solvent (e.g. cyclohexane) 
that is emulsified in an aqueous phase. Upon evaporation of the solvent, nanoparticle 
dispersion is formed by precipitation of the lipid in the aqueous medium. Siekmann and 
Westesen produced cholesterol acetate nanoparticles with a mean size of 29 nm using solvent 
emulsification/evaporation technique. 
 Other methods of lipid nanoparticle preparation include phase inversion and 
supercritical fluid (SCF) technology. 
2.9. CHARACTERIZATION OF LIPID NANOPARTICLE QUALITY 
Quantitative analysis of particle characteristics such as morphological features can be 
very informative as biophysical properties are known to influence biological activity, 
biodistribution and toxicity. Several techniques are often used to assess nanoparticle 
characteristics such as lamellarity, size, shape and polydispersity. Adequate and proper 
characterization of the lipid nanoparticles is necessary for quality control. However, 
characterization of lipid nanoparticles is a serious challenge due to the colloidal size of the 
particles and the complexity and dynamic nature of the delivery system. The important 
parameters which need to be evaluated for the lipid nanoparticles are particle size, size 
distribution kinetics (zeta potential), degree of crystallinity and lipid modification 
(polymorphism), coexistence of additional colloidal structures (micelles, liposome, super 
cooled melts, drug nanoparticles), time scale of distribution processes, drug content 
(encapsulation efficiency and loading capacity), in vitro drug release and surface morphology 
(Anthony A. Attama et al., 2012). 
Particle size and size-distribution may be studied using photon correlation 
spectroscopy (PCS) otherwise known as dynamic light scattering (DLS), static light 
scattering (SLS), transmission electron microscopy (TEM), scanning electron microscopy 
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(SEM), atomic force microscopy (AFM), scanning tunneling microscopy (STM), freeze 
fracture electron microscopy (FFEM) or cryoelectron microscopy (Cryo-EM). These 
microscopy techniques are also used to study the morphology of nanoparticles. 
Among the imaging techniques, AFM has been widely applied to obtain the size, 
shape and surface morphological information on nanoparticles. It is capable of resolving 
surface details down to 0.01 nm and producing a contrasted and three-dimensional image of 
the sample. Xray diffraction and differential scanning calorimetric analysis give information 
on the crystalline state and polymorphic changes in the nanoparticles. Confocal laser 
scanning microscopy (CLSM) gives information on interaction of nanoparticles with cells. 
Nuclear magnetic resonance (NMR) can be used to determine both the size and the 
qualitative nature of nanoparticles. The selectivity afforded by chemical shift complements 
the sensitivity to molecular mobility to provide information on the physicochemical status of 
components within the nanoparticle. 
An important characterization technique for lipid nanoparticles is determination of 
solid state properties. This is very important in order to detect the possible modifications in 
the physicochemical properties of the drug incorporated into the lipid nanoparticles or the 
lipid matrix. It has been proven that although particles were produced from crystalline raw 
materials, the presence of emulsifiers, preparation method and high shear encountered (e.g. 
HPH) may result in changes in the crystallinity of the matrix constituents compared with bulk 
materials. This may lead to liquid, amorphous or only partially crystallized metastable 
systems. Polymorphic transformations may cause chemical and physical changes (e.g. shape, 
solubility, melting point) in the active and auxiliary substances. The solid state analysis of 
lipid nanoparticles is usually carried out using the following procedures: DSC, X-ray 
diffraction, hot stage microscopy, Raman spectroscopy and Fourier-transform infrared 
spectroscopy. 
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2.10. APPLICATIONS OF LIPID PARTICULATE DRUG DELIVERY SYSTEMS 
During the last decade, different substances have been entrapped into lipid 
nanoparticles ranging from lipophilic to hydrophilic molecules and including difficult 
compounds such as proteins and peptides. 
1. Lipid nanoparticles as carriers for oral drug delivery 
Lipid nanoparticles such as SLN can be administered orally as dispersion, SLN-based 
tablet, pellets or capsules or even as lyophilized unit dose powders for reconstitution for oral 
delivery. The stability of the particles in the GIT has to be thoroughly tested, since low pH 
and high ionic strength in the GIT may result in aggregation of the particles. In order to prove 
this, an investigation of the effect of artificial gastric fluids on different lipidic nanoparticle 
formulations was performed. The authors showed that a zeta potential of at least 8-9 mV in 
combination with a steric stabilization hinders aggregation under these conditions. 
Additionally, for oral drug delivery, a release upon enzymatic degradation has to be taken 
into account. 
The routes for particle uptake after oral application are transcellular (via the M cells in 
the Peyer‟s patches or enterocytes) or paracellular (diffusion between the cells). However, the 
uptake via M cells is the major pathway, resulting in the transport of the particles to the 
lymph. Uptake into the lymph and the blood was demonstrated by means of TEM and gamma 
counting of labelled SLN. It was found that uptake to the lymph was considerably higher than 
to the plasma and as such, a reduced first pass effect concludes, as the transport via the portal 
vein to the liver is bypassed. SLN containing the antituberculosis drugs rifampicin, isoniazid 
and pyrazinamide have been studied in animals model and it was found that administration 
every 10 days could be successful for the management of tuberculosis. 
2. Lipid nanoparticles for parenteral drug delivery 
Lipid nanoparticles can be formulated for subcutaneous, intramuscular or intravenous 
administration. For intravenous administration, the small particle size is a prerequisite as 
passage through the needle and possibility of embolism should be considered. SLN offer the 
opportunity of a controlled drug release and the possibility to incorporate poorly soluble 
drugs. Additionally, especially for intravenous application, drug targeting via modification of 
the particle surface is possible, and for SLN formulation with a controlled release, higher 
plasma concentrations over a prolonged period of time can be obtained. Such systems form 
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an intravenous depot. Further studies with different drugs such as idarubicin, doxorubicin, 
tobramycin, clozapine or temozolomide also showed a sustained release.  
3. Lipid nanoparticles as carriers for peptides and proteins drugs 
Lipid nanoparticles have been extensively studied for the delivery of proteins and 
peptides. Therapeutic application of peptides and proteins is restricted by their high 
molecular weight, hydrophilic character and limited chemical stability, which cause low 
bioavailability, poor transfer across biological membranes and low stability in the 
bloodstream. Most of the available peptides and proteins are delivered by injection, but their 
short half life demands repeated doses that are costly, painful and not well tolerated by 
patients. Lipid nanoparticles could be useful for peptide and protein delivery due to the 
stabilizing effect of lipids and to the absorption promoting effect of the lipidic material that 
constitute this kind of nanoparticles. The use of niosomes and liposomes as adjuvants for the 
delivery of Newcastle disease virus to chicks has been reported. 
4. Lipid nanocarriers for nasal vaccination 
The use of lipid nanocarriers provides a suitable way for the nasal delivery of 
antigenic molecules. Besides improved protection and facilitated transport of the antigen, 
nanoparticulate delivery systems could also provide more effective antigen recognition by 
Immune cells. These represent key factors in the optimal processing and presentation of the 
antigen, and therefore in the subsequent development of a suitable immune response. In this 
sense, the design of optimized vaccine nanocarriers offers a promising way for nasal mucosal 
vaccination. 
5. Lipid nanoparticles as carriers in cosmetic and dermal preparation 
Lipid nanoparticles can be incorporated into a cream, hydro gel or ointment to obtain 
semisolid systems for dermal applications. Another possibility is to increase the amount of 
lipid matrix in the formulation above a critical concentration, resulting in semisolid 
formulations. The substances used for the preparation of dermal SLN are rather innocuous 
since they are mostly rated as GRAS and many of them are used in conventional dermal 
formulations. This resulted in the first dermal formulations containing SLN for cosmetic 
purposes entering the market. 
Due to the adhesiveness of small particles, SLN adhere to the stratum corneum 
forming a film as this films have been shown to possess occlusive properties. It was shown 
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that the degree of crystallinity has a great impact on the extent of occlusion by the 
formulation. With increasing crystallinity the occlusion factor increases as well. This explains 
why liquid nanoemulsions in contrast to SLN do not show an occlusive effect and why the 
extent of occlusion by NLC compared to SLN is reduced. Other parameters influencing the 
occlusion factor are the particle size and the number of particles. Whilst with increasing size 
the factor decreases, an increase in number results in an increase in the extent occlusion. The 
occlusive effect leads to reduced water loss and increased skin hydration. Highly crystalline 
SLN can be used for physical sun protection due to scattering and reflection of the UV 
radiation by the particles. A high crystallinity was found to enhance the effectiveness and was 
also synergistic with UV absorbing substances used in conventional sunscreens. Similarly 
synergism was observed on the sun protection factor and UV-A protection factor exhibited by 
the incorporation of the inorganic sunscreen, titanium-dioxide in NLC of carnauba wax and 
decyl oleate. 
6. Lipid nanoparticles for ocular application 
The eye possesses unique challenges with respect to drug delivery especially with 
respect to the posterior segment and treating vision threatening diseases. Poor bioavailability 
of drugs from ocular dosage form is mainly due to the pre-corneal loss factors which include 
tear dynamics, non-productive absorption, transient residence time in the cul-de-sac, and 
relative impermeability of the corneal epithelial membrane. Due to the adhesive nature of the 
small nanoparticles, these negative effects can be reduced. For ocularly administered SLN an 
increase in bioavailability was observed in rabbits by Cavalli et al. using tobramycin ion pair 
as the model drug. Various in vitro studies show a prolonged and enhanced permeation when 
the drug is incorporated in lipid nanoparticles. For systems containing phospholipids, a 
further improved permeation of diclofenac sodium was observed.  
7. Pulmonary application of lipid nanoparticles 
Pulmonary drug application offers the advantage of minimizing toxic side effects if a 
local impact is intended. Systemic delivery can be achieved through pulmonary delivery, 
offering the advantage of bypassing the first pass effect, as well as offering a large absorptive 
area, extensive vasculature, easily permeable membrane and low extracellular and 
intracellular enzyme activities. A problem of this method of administration is the low 
bioavailability. SLN can easily be nebulised to form an aerosol of liquid droplets containing 
nanoparticles for inhalation. In vivo studies showed that the administered drugs (rifampicin, 
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isoniazid and pyrazinamide for the treatment of tuberculosis) resulted in a prolonged mean 
residence time and a higher bioavailability than the free drug. 
8. Application of liquid crystal drug delivery systems 
The spontaneous self assembly of some lipids to form liquid crystalline structures 
offers a potential new class of sustained release matrix. The nanostructured liquid crystalline 
materials are highly stable to dilution. This means that they can persist as a reservoir for slow 
drug release in excess fluids such as the GIT or subcutaneous space, or be dispersed into 
nanoparticle form, while retaining the parent liquid crystalline structure. The rate of drug 
release is directly related to the nanostructure of the matrix. The particular geometry into 
which the lipids assemble can be manipulated through either the use of additives to modify 
the assembly process, or through modifying conditions such as temperature, thereby 
providing a means to control drug release. 
Liquid crystal depot could be injected as a low-viscosity solution. Once in the body, 
itself assembles and encapsulates the drug in a nanostructured, viscous liquid crystal gel. The 
drug substance is then released from the liquid crystal matrix over a time period, which can 
be tuned from days to months. The liquid crystal depot system is capable of providing in vivo 
sustained release of a wide range of therapeutic agents over controlled periods of time. Liquid 
crystal nanoparticles can be combined with controlled-release and targeting functionalities. 
The particles are designed to form in situ at a controlled rate, which enables an effective in 
vivo distribution of the drug. The system has been shown to give more stable plasma levels of 
peptides in comparison to competing microsphere and conventional oil depot technologies.  
Oral liquid crystal DDS are designed to address the varied challenges in oral delivery 
of numerous promising compounds including poor aqueous solubility, poor absorption, and 
large molecular size. Compared with conventional lipid or non-lipid carriers, these show high 
drug carrier capacity for a range of sparingly water-soluble drugs. For drugs susceptible to in 
vivo degradation, such as peptides and proteins, liquid crystal nanoparticles protect the 
sensitive drug from enzymatic degradation. The system also addresses permeability 
limitations by exploiting the lipid-mediated absorption mechanism. For water soluble 
peptides, typical bioavailability enhancements range from twenty to more than one hundred 
times. In an alternative application large proteins have been encapsulated for local activity in 
the GIT. Liquid crystal nanoparticle systems can be designed to be released at different 
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absorption sites (e.g., in the upper or lower intestine) which is important for drugs that have 
narrow regional absorption windows. 
With regards to topical application, liquid crystal systems form a thin surface film at 
mucosal surfaces consisting of a liquid crystal matrix, whose nanostructure can be controlled 
for achieving an optimal delivery profile. The system also provides good temporary 
protection for sore and sensitive skin. Their unique solubilizing, encapsulating, transporting, 
and protecting capacity is advantageously exploited in liquid and gel products used to 
increase transdermal and nasal bioavailability of small molecules and peptides. 
Advantages of Lipid based drug delivery system (LBDDS) 
(1) Drug release in controlled and targeted way. 
(2) Pharmaceutical stability. 
(3) High and enhanced drug content (compared to other carriers). 
(4) Feasibilities of carrying both lipophilic and hydrophilic drugs.  
(5) Biodegradable and biocompatible. 
(6) Excipients versatility. 
(7) Formulation versatility. 
(8) Low risk profile. 
(9) Passive, noninvasive formation of vesicular system which is available for immediate  
     Commercialization. 
2.11. NUTRACEUTICALS 
When a functional food aids in the prevention and/or treatment of disease(s) and/or 
disorder(s) (except anemia), it is called a nutraceutical. The proposed definition can help 
form distinction between functional foods, nutraceuticals, and dietary supplements. 
The term "nutraceutical" was coined from "nutrition" and "pharmaceutical" in 1989 
by Stephen DeFelice, MD, founder and chairman of the Foundation for Inno-vation in 
Medicine (FIM), Cranford, NJ.1 According to DeFelice, nutraceutical can be defined as, "a 
food (or part of a food) that provides medical or health benefits, including the prevention 
and/or treatment of a dis-ease."1 However, the term nutraceutical as commonly used in 
marketing has no regulatory definition (Ekta K. Kalra et al., 2014) 
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2.12. Tetrahydrocurcumin bioavailability 
Curcumin, a polyphenolic compound extracted from the rhizomes of turmeric 
(Curcuma longa Linn.), has a wide biological and pharmacological profile. It has also been 
reported to possess anti-oxidative, anti-inflammatory, anticarcinogenic, and gastroprotective 
effects (Ruby AJ et al.,). Tetrahydrocurcumin(THC), one of the major metabolites of 
curcumin invivo (Pan MH et al.,) was reported to exhibit the same physiological and 
pharmacological properties of curcumin. THC has been widely used in pharmaceutical and 
cosmetic preparations. THC, in a white to off-white powder form, has a molecular weight of 
372.41 Da and a melting point of 85–100°C. THC is insoluble in water and soluble in 
alcohol, acetone, and glacial acetic acid. However, the pharmacological effect of THC is 
limited due to its low aqueous solubility. In addition, a relative short gastric emptying time 
can result in an incomplete release of THC from the dosage form at the site of absorption and 
lead to a diminished efficacy of the administered dose. 
 Based on the available literatures the therapeutic potential of THC can be achieved by 
making it as NLC formulation with improved bioavailability. The present investigation is 
focused on the development of THC nanostructure Lipid carrier with enhanced 
bioavailability.  
2.13. ESSENTIAL OIL AS NATURAL PRESERVATIVES 
Infections due to bacterial species also remain a serious clinical problem. Emerging 
resistance of bacterial species is seriously decreasing the number of effective antimicrobials. 
Because of increasing pressure of consumers and legal authorities, the food industry has 
tended to reduce the use of chemical preservatives in their products to either completely nil or 
to adopt more natural alternatives for the maintenance or extension of product shelf life. 
Plants and their essential oils are potentially useful sources of antimicrobial compounds. 
Numerous studies have been published on the antimicrobial activities of plant compounds 
against many different types of microbes, including food-borne pathogens. The main 
constituents of essential oils – mono- and sesquiterpenes including carbohydrates, phenols, 
alcohols, ethers, aldehydes and ketones – are responsible for the biological activity of 
aromatic and medicinal plants as well as for their fragrance. Due to these properties, spices 
and herbs have been added to food since ancient time, no only as flavouring agents but also 
as preservatives (Marina Soković, Jasmina Glamočlija et al.,2010) 
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2.14. NATURE’S ALTERNATIVES TO SYNTHETICS 
It‟s important for an educated consumer to understand what elements make an 
effective product. All skin care products (synthetic, organic and everything in between) 
contain the functional ingredients that serve as emollients, humectants, emulsifiers, 
surfactants and preservatives in some combination or another in order to produce effective 
products.  
There is no reason we need to rely on chemicals to make a product work or even to 
preserve it. There are hundreds of natural ingredients that outperform synthetics and 
generally render synthetic chemicals obsolete! (Abhishek Jain, Pinky Radiya et al., 2014) 
1. EMOLLIENTS 
Emollients serve two functions; they prevent dryness and protect the skin acting as a 
barrier and healing agent. Water is the best emollient, but it doesn‟t work well for products 
because it evaporates quickly. In order for a product to be an effective moisturizer some sort 
of emollient oil needs to create emulsion so the skin can absorb the product. 
Natural Emollients 
 Natural emollients actually nourish the skin are recognized and metabolized by the 
skin‟s own enzymes and absorbed into it. These ingredients are provided by nature, 
thus readily biodegradable. There are no contamination concerns and these 
ingredients are of edible quality as pure as food. 
 Some examples of natural emollients are Plant Oils (eg. Jojoba, Avocado, Rosehip) 
and Shea, Cocoa and Jojoba Butters 
Synthetic Emollients 
 
 Synthetic Emollients are occlusive, meaning they coat the skin and do not allow it to 
“breathe” or respire (much like plastic wrap), which can cause skin irritation. Some 
synthetic emollients have been proven to accumulate in the liver and lymph nodes of 
the body. Finally, synthetic emollients are not biodegradable and create a negative 
environmental impact. 
 Some examples synthetic emollients are PEG Compounds, as in PEG- 45; Synthetic 
Alcohols, as in anything that contains the phrase benzyl –, butyl-, cetearyl-, cetyl -, 
glyceryl-, isopropyl-, myristyl propyl-, propylene-, or stearyl-); Hydrocarbons, as in 
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mineral oil, petrolatum, paraffin; Silicone oils, as in dimethicone, cyclomethicone, 
copolyol. 
2. HUMECTANTS 
The main purpose of a skin cream is to keep the skin moist and that function is served 
by the product‟s humectants. 
Natural Humectants 
 
 Natural phospholipids, from lecithin, are fantastic humectants. An important benefit 
of phospholipids is that they are hygroscopic (attract water from the surrounding air) 
and hold water where an increased level of hydration is needed. 
 Therefore, phospholipids increase the hydration levels of the skin without being 
occlusive (forming a film to prevent water loss, and preventing normal cellular 
function). 
 A recent study proved the value of topically applied phospholipids in skin care. It 
found that environmental factors (sun, wind, pollution) and the detergents and 
solvents found in most skin cleansers, actually stripped the natural phospholipid 
content from the top layer of skin. 
 This loss resulted in a rough feel and a pitted appearance under a microscope. 
Importantly, the phospholipids in the uppermost skin layers cannot be replaced by 
natural cell function, as the top layer of cells no longer metabolize; they serve only as 
a protective barrier. 
 Remarkably, the study showed that topically applied plant phospholipids restore the 
barrier function of the skin, protecting it from substances such as bacteria and harmful 
synthetic chemicals. 
 Some examples of natural humectants are Lecithin, Panthenol (pro-vitamin B5), 
Glycerin 
Synthetic Humectants 
 Many conventional creams using synthetic humectants form a suffocating film on the 
skin to prevent moisture loss. 
 Some examples of synthetic humectants are Propylene Glycol, Ethylene/Diethylene 
Glycol, PEG compounds (eg. Polyethylene Glycol), Synthetic alcohols (eg Glyceryl 
Coconate, Hydroxystearate, Myristate, Oleate) 
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3. EMULSIFIERS 
Emulsifiers blend and hold together ingredients that don‟t normally mix. An 
emulsifier can either be a physical substance (like wax) or a physical action (like “shake well 
before use”). 
Natural Emulsifiers 
 
 Natural emulsifiers are obtained from various nuts, berries and leaves 
 Some examples of natural emulsifiers are Plant Waxes (eg. Candelilla, Carnauba, 
Jojoba, Rice Bran), Xanthan Gum, Quince Seed 
Synthetic Emulsifiers 
 
 Synthetic emulsifiers are usually petroleum/hydrocarbon derivatives 
 Some examples of synthetic emulsifiers are Alkoxykated Amides (eg TEA, DEA, 
MEA, MIPA compounds), PEG compounds, Sorbitan Stearate, Laurate, Palmitate, 
Oleate, Ceresin, Silicone, Isopropyl Stearate.  
4. SURFACTANTS 
Surface-active-agents are substances capable of dissolving oils and holding dirt in 
suspension so it can be rinsed away with water. They are used in skin cleansers and 
shampoos. 
Natural Surfactants 
 Natural saponins (foaming agents) are a superior surfactant choice for shampoos and 
body washes as they gently cleanse the hair and scalp without stripping the natural 
oils. Natural cleansers create the perfect balance of mildness, effective cleansing, 
scalp and skin nourishment and protection. 
 Some examples of natural surfactants are Castile Soap, Yucca Extract, Soapwort, 
Quillaja Bark Extract 
Synthetic Surfactants 
 Most synthetic surfactants are inexpensively produced, excessively harsh, stripping 
and irritating to skin and scalp. 
 Another serious problem with ethoxylated surfactants (those that utilize ethylene or 
propylene oxide in the chemical reaction) is that they can be contaminated with 
dioxane, a potent carcinogen. These surfactants are listed on labels as ingredients 
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ending with –eth, (like laureth) or containing the phrase PEG (PolyEthylene Glycol), 
or PPG (PolyPropylene Glycol). 
 Another potentially unsafe class of synthetic surfactants are amides. These are listed 
on labels containing the term TEA – TriEthanolAmine, DEA – DiEthanolAmine and 
MEA, MonoEthanolAmine. All compounds containing TEA, DEA and MEA can 
undergo nitrosation with other synthetic chemicals to form nitrosamines, which are 
carcinogenic. 
 Some examples of synthetic surfactants are Sodium or Ammonium Lauryl or Laureth 
Sulphate, Sodium Methyl Cocoyl Taurate, Sodium Lauroyl or Cocoyl Sarcosinate 
Cocomidopropyl Betaine, TEA (Triethanolamine) compounds, DEA 
(Diethanolamine) compounds, MEA (Monethanolamine) compounds, PEG 
(Polyethylene Glycol) compounds, Quaternium -7, 15, 31, 60 etc, Lauryl or Cocoyl 
Sarcosine Disodium Oleamide or Dioctyl Sulfosuccinate.  
5. PRESERVATIVES 
Preservatives are used to protect products from bacteria and mold and give them a 
longer shelf life. In all matter, the decaying process is natural and will eventually occur with 
or without preservatives of any kind. Skin care products do not, and should not, last forever. 
Natural Preservatives 
 Another Miessence exclusive is the all natural and organic preservation system we 
feature in our products. This proprietary formulation is a combination of 6 different 
herbal, fruit and flower extracts, which varies from product to product. 
 Just like food, all natural skin care products will eventually deteriorate and go rancid, 
you will just have to pay mind to the Miessence “fresh by dates” and “use by dates”. 
Read more on our Preserving Products Naturally page. 
 Miessence has also developed distinctive airless vacuum pumps for many of our 
bottles, highly desirable for naturally preserved products due to the fact that it keeps 
air and airborne contaminants out of the bottles. This feature significantly assists the 
function of our natural preservative system and shelf life of our products. 
 Some examples of natural preservatives are Tea Tree Essential Oil, Thyme Essential 
Oil, Grapefruit Seed Extract, Bitter Orange Extract 
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Synthetic Preservatives 
 
 Synthetic chemical preservatives are toxic by nature since it is their chemical purpose 
to kill bacteria and mold for years and years. All synthetic preservatives are 
considered toxic in high doses, but manufacturers argue the small amounts in products 
are harmless. Since human safety testing does not exist for 89% of synthetic 
chemicals used in personal care products, we will have to wait for conclusive 
evidence. 
 Some examples of synthetic preservatives are Imidiazolidinyl Urea (formaldehyde 
donor, releases formaldehyde if temperature over 50 degrees Fahrenheit), DMDM 
Hydantoin (also contains formaldehyde), Methyl, Propyl, Butyl and Ethyl Parabens, 
Benzalkonium Chloride, Chloromethylisothiazolinone and Isothiazolinone, 
Methylisothiazolinone and Methylchloroisothiazolinone, Butylated Hydroxytoluene 
(BHT) and Butylated hudroxyanisole (BHA).  
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3. AIM AND OBJECTIVES 
Lipid based formulations usually contain lipid (soild or liquid) dispersed in aqueous 
solution of surfactant (or co-surfactant). Nano structured lipid carriers are proved to be 
suitable carriers with various advantages like (i) controlled release of the drug (ii) increased 
drug stability (iii) high drug loading (iv) no bio toxicity of the carrier (v) avoidance of 
organic solvents and (vi) no problems with respect to large scale production and sterilization. 
But, they often show poor stability due to microbial growth. Moreover, the problem of 
bacterial resistance to conventional preservatives has been observed in recent years. 
Traditionally used chemical preservatives often cause skin irritation and lead to allergenic 
reactions. All these factors have contributed to a search for alternative preservative systems. 
Hence, there is a lacuna to identify a natural preservative which can enhance the stability of 
lipid based formulations.   
These natural lipids (oils) have high oxidative resistance and are biocompatible, with 
no deleterious effects on the skin. The exotic fats used in skin care are known to exhibit their 
effects through restoration of a sufficient layer of skin lipids and skin elasticity, boost natural 
skin regeneration and increased skin hydration by forming an inert, epicutaneous occlusive 
membrane. Besides these facts, cocoa butter, mango butter, mineral and petroleum which is 
one of several exotic fats is viewed as an ingenious replacement for chemicals based lipid fat 
because of its appreciable contents which are very important as source of skin active 
ingredients. 
Furthermore, using of natural surfactants is viewed as alternative to replace helping to 
reduce contamination of the environment with drug particles. Like conventional properties 
offers exceptional surfactant blends with a balanced combination and dermatological 
properties in cosmeceuticals products. Therefore, the suitable use of a base surfactant or a co-
surfactant in cosmetic cleansing preparations is attractive in the recent past. Natural 
surfactants show a lower irritation potential in comparison to other surfactants and 
confirming the excellent suitability.   
An idea of natural preservatives seems to be very promising and practical in terms of 
availability and eco friendly nature. Nowadays much attention has been focused on essential 
oils (EOs) that demonstrate antimicrobial activities and have been proposed as natural 
preservatives. Recent studies provided evidence that different mechanisms are involved in 
antibacterial activity of essential oils (EOs). EOs is usually considered safe due to their 
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natural origin. Although most EOs is regarded as safe, some of them may cause risk of 
irritation, sensitization, phototoxicity or allergic reactions including anaphylaxis. EOs are 
also effective in controlling bacterial and fungicidal activity, which is an important criteria of 
a preservative. 
Growing demands for more natural and preservative- free cosmetics promoted an idea 
of the replacement of synthetic preservatives with essential oils (EOs) of antimicrobial 
properties. The antimicrobial effect of essential oil depends on content, concentration and 
interactions between the main active compounds. Effective preservatives should be 
characterized by a broad spectrum of antimicrobial activity at a minimum concentration. 
Based on these facts, the aim of this work is to develop a natural preservative system 
using essential oils with antimicrobial activity to enhance the preservation of nutricosmetics 
which are prepared using natural lipids and surfactants. For this purpose, nanostructured lipid 
carriers of tetrahydrocurcumin would be prepared with using essential oils with enhanced 
stability. The project would be carried out with the following objectives: 
 To screen out various essential oils for their antimicrobial activity and evaluation of 
their minimum inhibitory concentration against different bacterial strains. 
 To develop nano structural lipid carriers (NLC’s) and lipid based cream of 
Tetrahydrocurcumin (THC).  
 To characterize and optimize the NLCs and lipid based cream of Tetrahydrocurcumin. 
 To evaluate the stability of the NLCs and lipid based cream. 
 To evaluate the antimicrobial activity of NLCs and lipid based cream of 
Tetrahydrocurcumin. 
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4. PLAN OF WORK 
 Preformulation Studies 
 Development of analytical method by UV spectroscopy 
 IR spectroscopic Analysis 
 Evaluation of antibacterial activity of essential oils against various bacterial 
strains. 
 Determination of minimum inhibitory concentration of essential oils. 
 Determination of the stability of drug in different pH 
 Formulation development 
 Formulation of nanostructured lipid (NLC) carrier using Ultra probe 
sonication technology 
 Preparation of base cream using natural excipients 
 Incorporation of NLC into Base Cream  
 Characterization studies of the NLCs prepared 
 Determination of particle size, polydispersity index and zeta potential by Zeta 
sizer  
 Measurement of entrapment efficiency 
 Antimicrobial activity of NLCs and cream. 
 Visualization of morphology by Phase Contrast Microscopy (PCM) 
 Visualization of size, morphology and roughness by Atomic Force 
Microscopy(AFM) 
 Visualization of morphology by Scanning Electron Microscopy (SEM) 
 In vitro skin penetration study using pig ear skin 
 Evaluation of texture properties by Texture Analyzer. 
 Stability studies as per ICH guidelines 
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5. MATERIALS USED 
Table 3: Materials Used 
SL.NO. MATERIALS SOURCE 
1.  Tetra Hydro Curcumin Sami labs, Bangalore 
2.  Cocoa Butter National chemicals, vadodara, Gujarat 
3.  Soya lecithin Applichem  
4.  Lanolin Hi- Pure, Chennai 
5.  Bees wax Loba Chemie Pvt. Ltd., Mumbai 
6.  Cinnamon oil pure 
Sangrose Laboratories Pvt. Ltd., 
Mavelikara 
7.  Methanol Himedia Lab., Mumbai 
8.  Sodium hydroxide Himedia Lab., Mumbai 
9.  Potassium dihydrogen phosphate Fisher scientific, Mumbai 
10.  Glacial acetic acid Fisher scientific, Mumbai 
11.  Sodium chloride Himedia Lab., Mumbai 
12.  Beef extract Himedia Lab., Mumbai 
13.  Agar media Himedia Lab., Mumbai 
14.   Muller Hinton Agar Himedia Lab., Mumbai 
15.  Peptone extract Himedia Lab., Mumbai 
16.  Distilled Water Himedia Lab., Mumbai 
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 EQUIPMENTS USED 
Table 4: Equipments Used 
SL.NO. EQUIPMENT MODEL/COMPANY 
1. Digital Weighing Balance Shimadzu AY 220 
2. Magnetic Stirrer Remi Equipments Ltd 
3. Bath Sonicator RP 120 Ralsonics, Mumbai 
4. Ultra Probe Sonicator SONICS vibracell 
5. UV Visible Spectrophotometer UV-1650 PC Shimadzu 
6. FT IR Spectrophotometer 8400 S Shimadzu 
7. IR Hydraulic Pellet Press Model M15 Technosearch Instruments 
8. ELIZA reader Thermo Scientific 
9. Scanning Electron Microscope JEOL, Japan- JSM 6360 
10. Atomic Force Microscope  Multimode Scanning probe microscope 
(NTMDT, NTEGRA prima, Russia) 
11. Zeta Sizer Nano ZS90 Malvern UK 
12. Texture Analyzer TA-XT Plus 
13. Phase Contrast Microscope NIKON Inverted Fluorescent Microscope 
14. Gel doc Gel Doc System, Syngene 
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6. DRUG PROFILE 
TETRAHYDROCURCUMIN (THC) 
Chemical name                     : 1,7- bis (4-hydroxy 3 methoxy phenyl)-3,5 heptanedione 
Formula    : C21H24O6 
Structure   :  
    
Fig 4: Drug profile of Tetrahydrocurcumin 
Molecular weight  : 372.41 Da 
Physical state   : Solid 
Melting point   :           95-97
o
C 
Solubility             :  Water solubility- 0.0056 g/ l, freely soluble in  
acetone, glacial acetic acid 
Log P    : 3.51 
Log S    : -4.82 
Pka (strongest acidic) :  9.31 
Pka( strongest basic)  :  -4.6  
Hydrogen acceptor count : 6 
Hydrogen donor  : 2 
Polar surface area  : 93.06 A
2 
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Pharmacological actions : THC exhibits many of the pharmacological actions as  
that of curcumin. It has got many potent 
pharmacological actions like anti-oxidant property, anti-
cancerogenic and anti-angiogenic and prevents type II 
diabetes. It was also proved to be more effective than 
curcumin in preventing azoxymethane-induced colon 
carcinogenesis. 
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COCOA BUTTER 
Synonyms  : Cocoa oil, Cocoa fat, Cocoa bean oil 
Chemical name                   :     1,3-dipalmitoyl- 2-oleoyl-glycerol (POP), 1-palmitoyl- 
2-oleoyl-3-stearoyl-glycerol (POS), and 1,3-stearoyl-2-     
oleoyl-glycerol 
Empirical formula  : CH3(CH2)16COOH 
Molecular weight  :   
Structural formula  : 
 
Fig 5: Structure of Cocoa butter 
Melting point  : 34.1°C (93.4° F) 
Solidify  : Solidify at 20°C  
Refractive index  : 1.44556- 1.44573 
Iodine value  : 32.11- 35.12 
Acid value  : 1.68 
Saponification value  : 191.214 
Functional category  : It is used in lotions and skin care products like cream, facial 
washes, etc.,  
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SOYA LECITHIN 
Synonyms  : Lecithin from Soybean 
Chemical name  : (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2- 
   (trimethylazaniumyl)ethyl]phosphinate 
Empirical formula  : C35H66NO7P 
Molecular weight  :  643.887 g/mol 
Structural formula  : 
                                                
Fig 6: Structure of Soya Lecithin 
Solubility  : Soluble in ethanol and hot water 
Boiling point  : More than 80
o
C 
Functional category  : It acts as a wetting, stabilizing agent and a choline enrichment 
carrier, helps in emulsifications and encapsulation, and is a 
good dispersing agent. It can be used in manufacture of 
intravenous fat infusions and for therapeutic use. 
Storage  :  Soya lecithin should be stored at - 20˚C in a well-closed 
container, protected from light, in a cool, dry place. 
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CINNAMON OIL 
Synonyms  : Cassia oil, Chinese cinnamon,Cassia bark oil, Oil of cassia   
Chemical name  : 2-methoxy-4-prop-2-enylphenol;[(E)-prop-1-enyl]benzene 
Empirical formula  : C19H22O2 
Molecular weight  :  282.383 g/mol 
Structural formula  : 
 
Fig 7: Structure of Cinnamon oil 
Boiling point  : 194-234 °C 
Solubility  : Insoluble in water, soluble in alcohol 
Description  : It is of a golden-yellow colour, with the characteristic odour  
   of cinnamon and a very hot aromatic taste. The pungent and    
scent come from cinnamaldehyde (about 90% of the essential 
oil from the bark) and, by reaction with oxygen as it ages, it 
darkens in colour and forms resinous compounds. 
Functional catergory : Effective at treating skin conditions such as rashes, acne and 
infections, you can mix cinnamon essential oil with a carrier 
oil ( like coconut oil) and apply it to the skin to take 
advantage of its antimicrobial activity 
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BEES WAX 
Synonyms  : Triglyceryl beeswax 
Chemical name  : hexadecan-1-ol;2-methyloxirane;oxirane 
Empirical formula  : C21H44O3 
Molecular weight  :  344.58 g/mol 
Structural formula  : 
 
Fig 8: Structure of Bees wax 
Boiling point  : 98 to 99 °C°C 
Melting point  : 62 °C to 64 °C 
Flash point  : 204.4 °C 
Density  : 15 °C is 958 kg/m³ to 970 kg/m³ 
Description  : When natural beeswax is cold it is brittle, during on room     
         temperature it is tenacious, its fracture is dry and granular, it       
    also softens at human body temperature 
Functional catergory : Purified and bleached beeswax is used in the production of  
   food, cosmetics, and pharmaceuticals. 
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LANOLIN 
 
Synonyms  : Wool wax or Wool grease, Anydrous lanolin 
Melting point  : 38 °C to 42° C 
Density  : 0.932-0.945 g/cm3 
Description  : It is odourless, tasteless and yellow in colour 
Solubility  : Practically insoluble in water. Sparingly sol in cold, more in  
   hot alcohol; freely sol in chloroform, ether.  
Storage  : Store in a tightly closed container. Store in a cool, dry, well- 
   ventilated area away from incompatible substances. 
Functional catergory : Lanolin is used as emulsifing agent, binder, skin conditioner    
   and increasing viscosity agent in cosmetic purpose 
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7. PREFORMULATION STUDIES 
Preformulation studies involve physical, chemical and biological characterization of 
new drug substances in order to develop stable, safe and effective dosage form. 
Preformulation testing encompasses all studies enacted on a new drug compound in order to 
produce useful information for subsequent formulation of a stable and bio-pharmaceutically 
suitable drug dosage form. 
7.1. Analytical methods for Tetrahydrocurcumin (THC) 
 UV Spectrophotometric estimation of Tetrahydrocurcumin  (European 
Pharmacopoeia 6.0) 
7.1.1. Determination of lambda max: 
Tetrahydrocurcumin: 
A concentration of 100μg/ml solution of THC, were prepared and scanned under UV 
Visible Spectrophotometer from 200 to 400nm. The corresponding peak with the highest 
absorbance was taken as the lambda max for quantifying THC.  
Tetrahydrocurcumin standard solution (100μg/ml) showed highest peak at 281nm. 
From the UV-Vis spectrum (Graph 1) the lambda max of the THC was optimized as 281nm 
and used for further studies. 
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7.1.2. Lambda max of Tetrahydrocurcumin:  
Fig 9 :  UV Spectrum of Tetrahydrocurcumin 
 
7.2. Compatibility studies 
The sample of tetrahydrocurcumin of about 10mg was mixed with 100mg of KBr to 
make the pellet and scanned under FT-IR spectroscopy from 400 – 4000 cm-1. 
7.2.1. IR Spectrum of Tetrahydrocurcumin  
Characteristic peaks for carbonyl group C=O stretching was observed in 1601 cm-
1 
,  
C-C Stretching at 1515 cm-
1 
and  C-O stretching at 1233 which is evident that three peaks are 
confirming the purity of tetrahydrocurcumin molecule. 
7.2.2. IR Spectrum of Cocoa Butter 
Characteristic peaks for carbonyl group C=H stretching was observed in 1350 cm-
1 
,  
O-C=O  Stretching at 2902 cm-
1 
and  Triglycerides stretching at 1738 cm-
1 
 which is evident 
that three peaks are confirming the purity of tetrahydrocurcumin molecule. 
7.2.3. IR spectra of physical mixture of Tetrahydrocurcumin and Cocoa Butter 
The characteristic peaks for CH3 stretching at 2946 cm-
1
, C=H stretching at 1350 cm-
1 
, O-C=O stretching at 2902 cm-
1 
, Carbonyl stretching at 1757 cm-
1 
and OH stretching at 
3420 cm-
1 
was observed in the IR spectra of physical mixture of drug and lipid. This confirms 
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that the molecule under study, THC has not undergone any structural changes. Thus no 
incompatibility issue is observed with the lipid used. 
Fig 10 :  IR Spectra of Tetrahydrocurcumin 
 
Fig 11 :  IR Spectra of Cocoa Butter 
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Fig 12: IR spectra of physical mixture of THC and Cocoa Butter 
 
7.3. Calibration Curve  
Phosphate buffer pH 7.4 was used as the buffering medium in the preparation of 
standard solution of Tetrahydrocurcumin  
Standard graph for THC 
 Primary stock solution of THC was prepared by dissolving 10mg of THC is dissolved 
in methanol in a 100ml of volumetric flask until it soluble and make up with water. Aliquots 
of THC was prepared from stock solution in the concentration range of 2 μg/ml, 4 μg/ml, 6 
μg/ml, 8 μg/ml, 10 μg/ml, 12 μg/ml, 14 μg/ml, 16 μg/ml, 18 μg/ml, 20 μg/ml in 10ml 
volumetric flask using Phosphate buffer pH 7.4 in buffer as solvent. The absorbance of THC 
standard solutions was measured at 281 nm (lambda max of THC) against Phosphate buffer 
pH 7.4 in buffer solution as blank. The standard graph was prepared with concentration of 
solution (in µg/ml) on X-axis and absorbance on Y-axis. The results are shown in fig 8. 
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Table 5: Standard Table for Tetrahydrocurcumin 
Sl.no Concentration (µg/ml) Absorbance at 281nm 
1.  2 0.051 
2.  4 0.100 
3.  6 0.135 
4.  8 0.196 
5.  10 0.218 
6.  12 0.248 
7.  14 0.300 
8.  16 0.359 
9.  18 0.368 
10.  20 0.406 
  
Fig 13: Calibration Curve of Tetrahydrocurcumin 
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7.4. SELECTION OF OILS 
Various Essential oils have been widely used for bactericidal, virucidal, fungicidal, 
ant parasitical, insecticidal, and other medicinal properties such as analgesic, sedative, anti-
inflammatory, spasmolytic, and locally anesthetic remedies. Essential oils  such as Neem 
oil,Clove oil,Eucalyptus oil,Orange oil,Peppermint Oil,Lemon grass Oil,Castor oil,Lavender 
Oil, Olive oil, Cinnamon oil tested for antibacterial activity against 7 Bacterial Strains.  
(Staphylococcus aureus, Enterococcus faecalis, Streptococcus aeruginosa, Salmonella 
typhimurium, E.coli, Klebseilla pneumonia,Candida albicans). 
Table 6: Antibacterial activity of Essential Oils 
Various 
Essential 
oils 
Strains 
Staphylococcus 
Aureus  
Solmonella 
typhimurium 
Enterococcus 
faccalis 
Pseudimonas 
aeroginosa 
E.coli Klebsiella 
pneumonia 
Candida 
albicans 
Neem oil 
Oil 
-- -- -- - -- -- -- 
Clove Oil     -       - 
Eucalyptus 
Oil 
    -       - 
Orange Oil - - - - - - - 
Peppermint 
Oil 
    -       - 
Lemon 
Grass Oil 
 -   -         
Castor Oil - - - - - - - 
Lavender 
Oil 
    -         
Olive Oil - - - - - - - 
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Fig 14: Images Of Zone Of Inhibition For Essential Oils 
Among this clove oil, peppermint oil, lemon grass oil, lavender oil, Cinnamon oil have well 
effect against bacteria.Neem oil has less bacterial activity presents in the active constituent of 
neem bark oil other than that it has fungal activity. 
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7.5. Mixed proportions of essential oils were studied for antimicrobial activity for E.Coli 
and Klebsiella strains 
Table 7: Mixed Proportion Of Essential Oils 
Clove Oil + Eucalyptus Oil (1:1) Clove Oil + Lavender Oil (1:1) 
Clove Oil + Peppermint Oil (1:1) Eucalyptus Oil + Peppermint Oil (1:1) 
Peppermint Oil + Lavender Oil (1:1) Clove Oil + Eucalyptus Oil + Peppermint Oil 
(1:1:1) 
Clove Oil + Eucalyptus Oil + Peppermint 
Oil + Lavender Oil (1:1:1:1) 
Clove Oil + Eucalyptus Oil + Peppermint Oil 
+ Neem Oi l (1:1:1:1) 
Clove Oil + Eucalyptus Oil + Peppermint 
Oil + Lavender Oil + Neem Oil (1:1:1:1) 
Cinnamon Oil + Neem Oil (1:1) 
 
 
Fig 15: Images of Zone of Inhibition for Mixed Proportion 
Here combination of oils shows lesser antibacterial activity than individual. 
Tetrahydrocurcumin NLCs loaded Nutricosmetics Preformulation Studies 
 
Department of Pharmaceutics, PSG College of Pharmacy 60 
 
7.6. DETERMINATION OF MINIMUM INHIBITORY CONCERNTRATION 
Method: 1 
 MIC determinations were performed in 96-wellmicroplates according to procedures 
described by the Clinical and Laboratory Standards Institute. The liquid media was prepared 
by adding 2% peptone, 0.5% Nacl, 0.3% beef extract in 100ml distilled water. Then 100µl 
liquid media was transferred into micro plate well. 100µl of essential oil were added in first 
well then serial two fold dilution was made. Add 5µl inoculum in each well.  The positive 
control comprised of media and organism and the negative control was liquid media. 
Inoculated micro plate were incubated for 24hrs at 37°C. Then absorbance were measured 
spectrometrically at 625 nm.    
                     Table 8:  Minimum inhibitory concentration for essential oils  
    
Control Absorbance 
Media 0.0470 
Media + Organism 0.1156 
  
 
 
Essential oil 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
Cinnamon oil 
 
0.1956
1956 
 
0.4966 
 
0.4074
0.4074 
 
0.2406
0.2406 
 
0.0921
0921 
 
0.0913
913 
 
0.0777
0.0777 
 
0.0843
843 
 
0.0751 
51 
 
0.0928
928 
 
0.0711.
0711 
 
Eucalyptus oil 
 
0.0568 
 
0.0791 
 
0.0736 
 
0.0768 
 
0.0786 
 
0.0999 
 
0.1606 
 
0.1432 
 
0.1417 
 
0.1314 
 
0.1382 
 
Peppermint oil 
 
0.6197 
 
0.1587 
 
0.0968 
 
0.0962 
 
0.0902 
 
0.1201 
 
0.1071 
 
0.1225 
 
0.1244 
 
0.1443 
 
0.1291 
 
Lavender oil 
 
0.2285 
 
0.1144 
 
0.1425 
 
0.0783 
 
0.1368 
 
0.1970 
 
0.1752 
 
0.2272 
 
0.1981 
 
0.2594 
 
0.1268 
 
 
 
Tetrahydrocurcumin NLCs loaded Nutricosmetics Preformulation Studies 
 
Department of Pharmaceutics, PSG College of Pharmacy 61 
 
Method :2  
 
All microbiological assays were performed under anaerobic conditions. MIC 
determinations were performed in 96-wellmicroplates according to procedures described by 
the Clinical and Laboratory Standards Institute. Each essential oil (200mg) was dissolved in 
dimethyl sulfoxide (40µL) and thevolume was made to 5 mL with sterile Muller Hinton 
medium containing 1%Tween 80 to provide a stock solution containing 40 mg mL
–1
of oil. 
Serial twofold dilutions of each essential oil stockwere made with Muller Hinton medium to 
yield final concentrations ranging from 20 to 0.625 mg mL
–1.
 The diluted samples (100 
µL)were transferred to microplate wells and mixed well withthe micropipette. The negative 
controls comprised sterile Muller Hinton medium or with dimethyl sulfoxide (at 
concentrations usedin the dilutions). In order to ascertain aseptic conditions, the control wells 
contained sterile Muller Hinton medium but withoutinoculum. The inoculated microplates 
were incubated at36 ± 1◦C for 48h under anaerobic conditions; and the bacterial growth was 
confirmed by adding 10µL of a sterile0.5% aqueous solution of triphenyltetrazolium chloride 
(TTC,Sigma–Aldrich) and incubating at 36◦C for 30min. Theviable bacterial cells reduced 
the yellow TTC to pink/red1,3,5-triphenylformazan (TPF). All assays were performed 
intriplicate. 
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Fig 16: Minimum Inhibitory Concentration for Peppermint Oil   
 
Fig 17: Minimum Inhibitory Concentration for Cinnamon Oil, Lavender Oil 
And Eucalyptus Oil 
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7.7. Determination of stability of drugs in different pH conditions 
Standard solution of the Tetrahydrocurcumin(THC) were prepared by dissolving 10 mg of 
standard drug in methanol  in 100 ml volumetric flask  until it soluble and make up with 
distilled water(1000µg/ml).  10 ml of Prepared standard solution of THC  was taken in 100 
ml volumetric flask in different medium such as HCL, Acetate, Phosphate pH 6.8 and 
Phosphate pH 7.4  with each individual buffers (1.2, 4.0, 6.8, 7.4) respectively (volume made 
up with respective buffer. Determine the initial absorbance (taken at 0
th
 hour) and consider it 
as 100 % of assay. Place the test solutions prepared in pH buffers at room temperatures and 
measure the absorbance (λmax = 280 nm) of the solutions at 2
nd
, 4
th
, 6
th
, 24
th
 and 48
th
 hours. 
Determine the concentration at each time point by correlating the absorbance value from the 
standard graph and report the changes from the initial concentration in assay %. 
Table 9: stability of drugs in different pH conditions 
Time (Hours) pH Absorbance (nm) 
0 
1.2 0.579 
4 0.550 
6.8 0.544 
7.4 0.562 
2 
1.2 0.564 
4 0.590 
6.8 0.539 
7.4 0.547 
6 
1.2 0.517 
4 0.541 
6.8 0.578 
7.4 0.520 
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24 
1.2 0.544 
4 0.533 
6.8 0.539 
7.4 0.552 
48 
1.2 0.540 
4 0.551 
6.8 0.544 
7.4 0.516 
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8. EXPERIMENTAL METHODOLOGY 
Nanostructured lipid carriers (NLC) are the second Generation solid lipid nano 
particles (SLN) composed of solid lipid matrix which are incorporated with liquid lipids. 
Among the nanostructured lipid carriers that contain solid lipids together with different liquid 
oils .The presence of liquid lipids with different fatty acid C-chains produces NLC with less 
organized crystalline structure and therefore provides better loading capacity for drug 
accommodation. Liquid lipids are better solubilizers of drugs than solid lipids. 
Approaching nano structured lipid carrier development from an emulsion perspective 
is faced with significant challenges. Numerous research groups subsequently commenced 
research efforts to improve nano structured lipid carrier development. Most researchers have 
approached traditional emulsion techniques. 
METHODS 
8.1. FORMULATION DEVELOPMENT 
Preparation of Nano Structured Lipid Carriers (NLC) by High Shear 
Homogenization coupled with ultra probe sonication 
 The solid lipid(500mg) of choice andthe liquid lipid (1ml)was mixed with the drug 
(100mg) andwarmed to 75°C for effective melting and mixing. Simultaneously, distilled 
water(20ml) to which the surfactant(300mg) has been incorporated is also heated to 75°C,it is 
instilled into the formulation herein. Thereafter, the aqueous part is added to the lipid part 
maintaining the temperature at 75°C, with continous stirring followed by magnetic stirring for 
3 mins. The two- phase system is then sonication using probe sonicator, at 20,000rpm for 
15min followed by ultra sonication for 2 min. The prepared formulations are stored at 
refrigeration condition until further use. 
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Fig 18: Schematic representation of the configuration of a Ultra Probe Sonicator 
8.2. CHARACTERIZATION STUDIES 
8.2.1. Particle size analysis  
 Photon correlation spectroscopy: 
The formulated NLCs dispersions were diluted with water /suitable solvent and the 
sample were analyzed for particle size by photon correlation spectroscopy technique using 
Zeta sizer (Nano ZS 90), Malvern, UK.  
 Zeta potential 
The prepared Nano structural Lipid  particle loaded with nutraceuticals of size 
distribution and the charge nature was analyze using Malvern zeta seizer. The suitable 
dilutions of the dispersions were made using water and it was scanned under version 6.30 by 
using disposable sizing cuvette at the count rate of 317.5 kcps for 60 sec at the measurement 
position of 4.6mm at attenuator 10. 
8.2.2. Entrapment efficiency: 
 1.5ml of the formulation was taken and subjected to centrifugation at 13000 rpm for 
50 min at 4°c. The supernatant was collected and the absorbance was measured at the 
corresponding lamda max of 281nm. 
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8.2.3. Experimental Design of NLCs 
 
In this study, a 2
3
 full-factorial experimental design was used to optimize NLCs. In 
order to optimize, the amount of Cocoa butter, concentration of Soya Lecithin  and volume of 
Cinnamon oil were selected as independent variables (factors). Each factor was set at a two 
high level and low level. Particle size, Zeta potencial, and % EE  were taken as response 
parameters. 
8.2.4. Microbial activity studies 
To compare the antimicrobial activity of tetrahydrocurcumin loaded nanostructured 
lipid carrier was carried out by using gram negative pathogenic strains (E.coli) and gram 
positive strains (Staphylococcus aureus) by disc diffusion method. This both strains was 
prepared and swap on petriplates for growing bacterial cultures contains nutrient agar. The 
prepared NLCs TNC 3 and TNC 4 was added in separate sterile disc and dryed in incubate for 
24 Hours. The disc containing NLCs formulation was placed in petriplate  with standard as 
control. Then, the bacterial petriplates were incubated at 37˚C for 24 Hours. The sensitivity of 
test organism to each extracts were indicated by clear zone of inhibition around the disc and the 
diameter of the zone of inhibition was measured.  
8.2.5. Phase contrast microscopy 
The samples was taken on glass slide and observed under Nikon leica inverted phase 
contrast microscope. Images were taken on computer monitor using leica software and shape 
of the particles was observed.  
8.2.6. Atomic Force Microscopy 
A small aqueous drop of prepared THC loaded NLCs  was adsorbed and dried to the 
surface of glass slide at room temperature. The images were examined on Multimode 
Scanning probe microscope (NTMDT, NTEGRA prima, Russia) in semi-contact mode with a 
force constant range of 0.35- 6.06 N/m and a resonating frequency range of 47- 150 KHz. The 
phase image and topology image were used to determine the morphology of the NLCs. 
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8.2.7. Scanning electron microscopy 
Scanning electron microscope (SEM) is a type of electronmicroscope that produces 
images of a sample by scanning it with a focused beam of electrons. The electrons interact 
with atoms in the sample, producing various signals that can be detected and that contain 
information about the sample's surface topography and composition. The surface 
characteristics of prepared NLC were examined by scanning electron microscope (SEM). The 
suspension was first put on clear glass stub, allowed to dry in air followed by coating with 
gold using Polaren E 5100 sputter coater and observed under microscope at 5.5x 
magnification. 
8.2.8. In vitro drug release studies: 
1 ml of NLCs  formulation was taken in Franz diffusion cell apparatus. A Pig ear skin 
was placed in a Frans diffusion cell containing Phosphate buffer pH 7.4  solution as medium 
at room temperature. At various predetermined intervals i.e., 2hr, 4hr, 6hr,8hr, 24hr, 48hr. 1ml 
of samples was withdrawn and replaced by buffer solution, to maintain the sink conditions. 
Cumulative % drug release in the samples were determined by measuring the absorbance 
under UV visible spectrophotometry and thereby extrapolating from the calibration curves. 
8.2.9. Preparation of Base Cream: 
In this study, O/W emulsion was prepared by the addition of aqueous phase to the oily 
phase with continuous agitation. To prepare the base, an lipid phase that consisted of Cocca 
butter (16gm), Bees wax (1.5gm), Lanolin (2.5gm). At the same time, aqueous phase 
consisting of Soya Lecithin (6gm) and distilled water (50ml) was heated to the same 
temperature. After heating, aqueous phase was added to the lipid phase with constant stirring. 
Stirring was continued at 2000 rpm by the mechanical mixer for 15 min until cream was 
formed.  
Incorporation of NLC into Base Cream 
 Prepared THC loaded NLC formulation (10ml) was incorporated into the 50g of Base 
Cream.  
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8.3. Texture analysis: 
 
Fig 19: Texture Analysis Image for THC loaded Cream 
8.3.1. Determination Of Spreadability Of Cream: 
The spreadability of the cream was determined by means of Texture Analyser (TA.XT 
plus) equipped with 5 kg load cell using spredability rig as fixture (figure ). This fixture 
consists of a heavy duty platform, male cone and a female cone.  The Heavy duty platform 
was placed on the base of the machine and locked in the desiredposition by tightening the 
screws. An empty femalecone sample holder was placed in the base holder. The male cone 
probe was attached above the female cone such that the male conefits almost all the wayinto 
the female cone sample holder and proper care is taken to align the cones in this position. The 
height of the male cone was calibrated against thefemale cone so that the starting point was 
25.0mm above the female cone (2 mm form the tip of the male cone and the sample). After 
calibration the sample was placed in the female cone sample holder and the test was run. The 
values of firmness (g) and work of shear (g s) were noted down by running macros. 
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8.3.2. Determination of Bloom Strength 
The bloom strength of the cream was determined by means of Texture Analyser 
(TA.XT plus) equipped with 5 kg load cell using a cylindrical probe of 0.5’’ diameter as 
fixture (figure ). The sample in the container was placed centrally on the platform beneath the 
cylindrical probe. After calibrating the height of the probe, the test was commenced. A trigger 
force of 10 g was used for the study. The test results are obtaining by running the macro. 
8.3.3. Extrudability of Cream: 
The cream were incubated at room temperature for 2 h before measuring their extrudability 
using an HDP/FE forward extrusion cell of the TA-XT2 Texture Analyser equipped with a 5 kg load 
cell (Stable Micro Systems, UK). Prior to measurement, the cream were manually stirred and loaded 
(100 g) into the cell. Compression force was measured at the following conditions: pre-test speed 1 
mm/s, test speed 1 mm/s, trigger force 50 g, post-test speed 10 mm/s, compression distance 20 mm, 
outlet diameter of extrusion cell 3 mm. The average force after reaching a plateau (at 10-15 s) was 
used as an indicator. 
8.4. Stability studies: 
 Particle size analysis and entrapment efficiency studies were conducted for 3 month to 
evaluate the stability of the formulations. The stability studies were carried out according to 
ICH guidelines.  The SLN formulations was stored at two different conditions i.e, 5 ± 3˚C 
(refrigeration conditions) and 25 ± 2˚C (room temperature).   
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9. RESULTS AND DISCUSSION 
The profound success of lipid based formulations for highly potent, lipophilic 
drug molecules have gained focus in this research field from the perspective of 
pharmaceutical industries. To increase the success rate of these lipids based 
formulations, there is a need to understand the excipients role. In this line, the present 
study is carried out to develop nano structured lipid carrier using the selected lipid 
with surfactants. 
9.1. FORMULATION DEVELOPMENT 
 Selection of Lipid 
 Cocoa butter was selected as the lipid carrier to formulate solid lipid 
nanoparticles of Tetrahydrocurcumin based on the results obtained from the 
entrapment and stability studies of the previous study. 
 Selection of Liquid lipid 
Cinnamon oil was selected as the liquid lipid as it is of natural origin with 
good antibacterial activity 
 Selection of Surfactant 
Soya lecithin was selected as a surfactant as it is of natural origin.  
9.2. Preparation of Nano Structured Lipid Carrier 
Ultra probe sonicator were used to formulate NLC of Tetrahydrocurcumin. 
Totally 8 formulations were prepared using by varying the concentration of  Solid 
lipid (Cocoa butter), one liquid lipid(Cinnamon oil), one surfactant (Soya Lecithin). 
The composition of the prepared NLCs was given in the table No 10. 
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Table 10: Formulation of Tetrahydrocurcumin loaded NLCs 
S.no Formulation 
Code 
Drug 
(mg) 
Lipid 
(mg) 
Surfactant 
(mg) 
Essential oil 
(ml) 
Water 
(mg) 
Remark 
1 TNC 1 100 500 400 0.5 20 Good 
Emulsion 
2 TNC 2 100 500 400 1 20 Good 
Emulsion 
3 TNC 3 100 500 300 0.5 20 Good 
Emulsion 
4 TNC 4 100 500 300 1 20 Good 
Emulsion 
5 TNC 5 100 1000 400 0.5 20 Creaming on 
storage 
6 TNC 6 100 1000 400 1 20 Creaming on 
storage 
7 TNC 7 100 1000 300 0.5 20 Creaming on 
storage 
8 TNC 8 100 1000 300 1 20 Creaming on 
storage 
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Fig 20: Formulation of THC loaded NLC (TNC 1- TNC 4) 
 
Fig 21: Formulation of THC loaded NLC (TNC 5- TNC 8) 
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9.3. PHYSICOCHEMICAL CHARACTERIZATION 
9.3.1. Particle Size Analysis 
The prepared nano structured lipid carrier was subjected to particle size 
analysis using Zeta sizer (nano ZS90, Malvern, UK). The formulations were 
sufficiently diluted with double distilled water prior to the measurement. The results 
showed that the particle size of prepared formulations were in the range of 50 to 190 
nm with good PDI.  
 The results suggest that the incorporation of different surfactant showed a 
difference in the aggregation pattern of prepared particles. This may be due to the 
difference in the solubility of lipid in surfactants. 
Table 11: Zeta sizer measurement results of THC loaded NLC 
Formulation code Particle size (nm) Zeta potential 
(mV) 
PDI  
TNC 1 192.1 -31.6 0.325 
TNC 2 136.9 -41.4 0.238 
TNC 3 163.2 -31.4 0.273 
TNC 4 55.9 -35.2 0.520 
TNC 5 138.9 -31.6 0.305 
TNC 6 83.55 -27.7 0.568 
TNC 7 111.2 -33.9 0.481 
TNC 8 50.85 -25.4 0.494 
 
 
Tetrahydrocurcumin NLCs loaded Nutricosmetics Results and Discussion 
 
`Department of Pharmaceutics, PSG College of Pharmacy 75 
 
Fig 22: Zeta size analysis of THC loaded NLC (TNC 1) 
Size distribution report by intensity 
 
 
Zeta potential report
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Fig 23: Zeta size analysis of THC loaded NLC (TNC 2) 
Size distribution report by intensity 
 
 
Zeta potential report 
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Fig 24: Zeta size analysis of THC loaded NLC (TNC 3) 
 Size distribution report by intensity 
 
 
Zeta potential report 
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Fig 25: Zeta size analysis of THC loaded NLC (TNC 4) 
Size distribution report by intensity  
 
                                                     
                                                      Zeta potential report  
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Fig 26: Zeta size analysis of THC loaded NLC (TNC 5) 
Size distribution report by intensity 
 
 
Zeta potential report 
 
 
 
 
Tetrahydrocurcumin NLCs loaded Nutricosmetics Results and Discussion 
 
`Department of Pharmaceutics, PSG College of Pharmacy 80 
 
Fig 27: Zeta size analysis of THC loaded NLC (TNC 6) 
 Size distribution report by intensity 
 
 
Zeta potential report 
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Fig 28: Zeta size analysis of THC loaded NLC (TNC 7) 
Size distribution report by intensity 
 
  
                 Zeta potential report 
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Fig 29: Zeta size analysis of THC loaded NLC (TNC 8) 
Size distribution report by intensity 
 
 
Zeta potential report 
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9.3.2. Entrapment efficiency 
The drug loading into the nanoparticles was determined by subjecting the 
formulations to centrifugation at 13000 rpm for 50 mins and supernatant was 
separated. The amount of free drug in the supernatant was measured 
spectrophotometrically at 281nm. A high drug loading was observed for all the 
formulations. Drug payload of 92.25% was observed for the formulation TNC 3. The 
results are depicted in table 12. 
Table 12:  Percentage entrapment of drug in NLC 
Formulation Entrapment Efficiency (%) 
TNC 1 89.16% 
TNC 2 87.79% 
TNC 3 92.25% 
TNC 4 90.91% 
TNC 5 79.33% 
TNC 6 81.11% 
TNC 7 87.77% 
TNC 8 88.07% 
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9.3.3. Experimental Design 
From the results of the preliminary experiments it was predicted that the 
content of liquid lipid, concentration of Solid Lipid and concentration of Surfactant 
were the important factors affecting particle size (PS), PDI, entrapment efficiency 
(EE). In order to optimize the formula ingredients, a 2
3
 full factorial experimental 
design was employed to study the effect of 3 independent variables (main factors) at 2 
levels (a high level and a low level) on dependent variables (responses). A two level 
full factorial design contains all possible combinations between the factors and their 
two levels. These designs allow estimating all main factors and interaction effects 
between the considered factors. The details of design are as per table 1.  The 
optimized batch was selected from among the solutions obtained for the criteria (all 
factors were kept in range, PS: minimum, EE: maximum) submitted in the design 
expert software [MiniTab software]. 
Table 13: Levels of independent variables 
Independent variables 
(Factors) 
Lower Level 
(%w/v) 
Upper Level 
(%w/v) 
Amount of Solid Lipid 500 1000 
Volume of Liquid Lipid 0.5 1 
Concentration of Surfactant 300 400 
 
On the basis of defined constraints for each independent variable, the MiniTab 
software automatically generated the optimized formula. The experimental values 
were obtained by preparing 8 batches of drug loaded NLCs and simultaneously 
evaluating them for response parameters (PS, ZP and EE) according to the optimized 
formula generated by the software. Calculation of percentage prediction was done to 
determine the accuracy of prediction by the software and the utility of the 
experimental design for modifying the NLCs with desirable parameters.  
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Regression Equation in Uncoded Units 
Size = 576.8 - 0.4733 Lipid - 903.7 Oil - 0.6910 Surfactant + 0.7530 Lipid*Oil 
+ 0.000918 Lipid*Surfactant + 1.984 Oil*Surfactant -
 0.001884 Lipid*Oil*Surfactant 
 
Regression Equation in Uncoded Units 
Zeta 
potential 
= -26.90 - 0.03620 Lipid + 12.20 Oil + 0.04700 Surfactant + 0.03240 Lipid*Oil 
+ 0.000022 Lipid*Surfactant - 0.1480 Oil*Surfactant 
+ 0.000056 Lipid*Oil*Surfactant 
 
Regression Equation in Uncoded Units 
Entrapment 
efficiency 
= 88.31 + 0.02892 Lipid + 3.280 Oil + 0.03800 Surfactant 
- 0.01156 Lipid*Oil - 0.000137 Lipid*Surfactant 
- 0.03080 Oil*Surfactant 
+ 0.000060 Lipid*Oil*Surfactant 
 
Table 14: Statistical values using 2
3
 factorial design 
Term Effect Coef 
SE 
Coef T-Value P-Value VIF 
Constant    88.31 * * *    
Lipid 0.05784 0.02892 * * * 500.00 
Oil 6.560 3.280 * * * 500.00 
Surfactant 0.07600 0.03800 * * * 100.00 
Lipid*Oil -0.02312 -0.01156 * * * 950.00 
Lipid*Surfactant -0.000274 -0.000137 * * * 590.00 
Oil*Surfactant -0.06160 -0.03080 * * * 590.00 
Lipid*Oil*Surfactant 0.000121 0.000060 * * * 1031.00 
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Fig 30: Influence on Experimental Design of Particle Size 
 
 
 
Fig 31: Influence on Experimental Design of Zeta Potencial 
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Fig 32: Influence on Experimental Design of % Entrapment Efficiency 
 
1. Increased amount of Cocoa butter and cinnamon oil caused an decrease in 
particle size. The fact that the size of lipid nanoparticles is highly dependent on lipid 
concentration can be explained in terms of tendency of lipid to coalesce at high lipid 
concentration. According to Stoke’s law, this behavior can be explained by difference 
in density between internal and external phase. Moreover, the decrease  in particle 
size might be because increased amount of lipid provides additional space for drug 
molecules to entrap, thus decreasing the total surface area. As a result, least for the 
TNC 4 that had the minimum particle size of 59 nm. 
 
2. On increasing the concentration of  Soya lecihin, the particle size was 
decreased. This might be due to the surfactant-induced reduction in surface tension 
between aqueous phase and organic phase. In addition, surfactant helps to stabilize the 
newly generated surfaces and prevents particle aggregation. The % EE was decreased 
because of the well-known fact that the aqueous solubility of drug increases with 
increasing concentration of surfactant in aqueous phase. However, the percent 
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cumulative drug release increased because of the corresponding decrease in particle 
size, which in turn increased the surface area available for dissolution. 
9.3.4. Microbial Activity study 
The antimicrobial activity of the prepared Tetrahydrocurcumin loaded NLCs 
was tested against E.coli and S.aureus by disc diffusion method. The antimicrobial 
activity was better for TNC 4 than TNC 3 against both the bacterial strains. The 
antimicrobial activity of NLC was compared against Standard as control.  
  
Figure 33: Anti microbial activity studies 
 
Table 15: Measurement of zone of inhibition of anti microbial activity studies 
 
S.no Bacterial Strains Zone of Inhibition(mm) 
TNC 3 TNC 4 Control 
1 E.coli 16 mm 26 mm 27 mm 
2 Staphylococcus aureus 13 mm 19 mm 19 mm 
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9.3.5. Phase Contrast Microscopy 
The Phase Contrast Microscope images for THC loaded NLC formulation, 
Formulation loaded cream shows particles are uniformly dispersed and it has 
spherical shape. 
 
 
TNC 4 – 10X 
Fig 34: PCM images showing the morphology of THC loaded NLC 
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9.3.6. SCANING ELECTRON MICROSCOPY 
The surface characteristics of prepared NLC were examined by scanning 
electron microscope (SEM). The suspension was first put on clear glass stub, allowed 
to dry in air followed by coating with gold using Polaren E 5100 sputter coater and 
observed under microscope at different magnification. 
 
 
                                      Fig 35: SEM Images of prepared NLC 
Scanning electron micrographs of NLC are shown in the above Figures 35. 
The shape of the NLC was spherical and the size of the NLC was found within the 
nanometer range. Aggregation was not observed among the particles. 
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9.3.7. ATOMIC FORCE MICROSCOPY (AFM) 
 
 
Fig 36: 2D image and 3D image of AFM analyzed particle 
Atomic Force Microscopy (AFM) study results indicate that the prepared 
NLCs formulation were spherical without any aggregation. 
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9.3.8. In Vitro Drug Release: 
 Table 16: In vitro Drug Release Study 
S.No Time (hrs) Cumulative % Drug 
Release 
1. 2hr 0.6% 
2. 4hr 4.05% 
3. 6hr 8.1% 
4. 8hr 11.45% 
5. 24hr 57.6% 
6. 48hr 96% 
 
 
Fig 37: In vitro permeation study across pig ear skin 
The in vitro release studies were carried up to 48 hours for the formulations 
and 96% of drug was penetrated through pig ear skin at 48hrs.  
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9.4. PREPARATION OF CREAM 
The cream was prepared using natural excipients like Cocoa butter (lipid), Soya 
Lecithin (Surfactant) and emulsifying waxes/agents. The emulsifying agents like acacia, agar, 
tragacanth, gelatin, bees wax and lanolin has been tested. Acacia and tragacanth did not form 
a stable cream. Although bees wax and lanolin forms stable emulsion in the beginning, the 
cream showed phase separation upon storage. Cream prepared using combination of bees 
wax and lanolin showed good stability over 3 months.    
Table 17: Preparation of cream with emulsifying agents 
Lipid  Surfactant  Acacia  Tragacanth  Agar  Gelatin  Glycerine  GMS  Remarks  
1gm  500mg  500mg  -  -  -  -  -  Separation  
1gm  500mg  1gm  -  -  -  -  -  Separation  
1gm  500mg  -  1gm  -  -  -  -  Suspension  
1gm  500mg  -  1.5gm  -  -  -  -  Thicky 
suspension  
1gm  500mg  -  -  1gm  -  -  -  Thicky solid  
1gm  500mg  -  -  -  300mg  -  -  Creamy but 
it precipitate  
1gm  500mg  -  -  -  200mg  -  -  Cream on 
Cooling  
1gm  500mg  -  -  -  100mg  -  -  Suspension  
1gm  500mg  -  -  -  100mg  5ml  -  Suspension  
1gm  500mg  -  -  -  -  10ml  -  Suspension  
1gm  500mg  -  -  -  -  -  500mg  Cream  
3gm  1.2gm  -  -  -  -  -  1gm  Cream  
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Table 18: Preparation of cream with emulsifying wax as Bees wax 
Lipid  Surfactant  Bees 
wax  
Almond 
Oil  
Cinnamon oil  Remarks  
3gm  1.2gm  500mg  -  -  Liquid  
3gm  1.2gm  700mg  -  -  Liquid  
3gm  1.2gm  1gm  -  -   
 
 
 
Thicky Cream  
3gm  1.2gm  1gm  0.5ml  -  
3gm  1.2gm  750mg  -  -  
3gm  1.2gm  750mg  0.5ml  -  
3gm  1.2gm  750mg  1ml  -  
3gm  1.2gm  750mg  1ml  0.5ml  
3gm  1.2gm  750mg  2ml  0.5ml  
3gm  1.2gm  750mg  3ml  0.5ml  
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Table 19: Preparation of cream with lanolin 
Lipid  Surfactant  Lanolin   oil  Remarks  
3gm  1.2gm  300mg  0.3ml  Cream on cooling  
3gm  1.2gm  200mg  0.3ml  Cream on cooling  
3gm  1.2gm  150mg  0.3ml  Suspension  
3gm  1.2gm  300mg  - Cream on cooling  
3gm  1.2gm  500mg  - Cream on cooling  
3gm  1.2gm  1gm  - Cream but not stable  
3gm  1.2gm  1gm  0.3ml  Cream on cooling  
3gm  2gm  1gm  - Cream on cooling  
 
Table 20: Preparation of cream with combination of Bees wax and lanolin 
Lipid  Surfactant  Bees wax  Lanolin  Remark  
3gm  1.2gm  500mg  1gm  Cream with Thicky  
3gm  1.2gm  500mg  500mg  Cream with Thicky  
3gm  1.2gm  300mg  500mg  Cream  
3gm  1.2gm  300mg  300mg  Cream with low stabe  
3gm  1.2gm  200mg  200mg  Suspension  
3gm  1.2gm  250mg  250mg  Cream with low stable  
 
The combination of bees wax with lanolin and base as lipid and surfactant have good 
formation of cream with no microbial growth 
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9.5. TEXTURE ANALYSIS 
9.5.1. Spreadability: 
Spreadability is the ease of which a product can be spread on skin. It is commonly a 
desired characteristic of ointments, gels, creams and waxes. It is related to the firmness of a 
product and more often than not the ease of spreading is associated with a loss in firmness. A 
good gel takes less time to spread and will have high spreadability. During the test the male 
cone approaches, penetrates and moves into the gel sample for a distance of 25mm from its 
start point. As the probe penetrates across the gel the force increases until a point of 
maximum penetration depth. This force value can be taken as the firmness at this specified 
depth. A firmer sample shows a correspondingly larger area that represents the total amount 
of force required to perform the shearing process. The probe then proceeds to withdraw from 
the sample. The maximum negative peak indicates the stickiness of the sample and the 
maximum negative area is taken as the work of adhesion. A stickier sample will require a 
greater force to remove the probe, yielding a larger negative area. Figure represents a typical 
spreadability graph of THC Cream. The firmness value obtained for THC Cream (593.330g) 
with force of application is (357.753g.sec).  
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Fig 38: Spreadability plot for THC loaded Cream 
9.5.2. Bloom Strength: 
Bloomstrength is a measure of the ability of a colloidal dispersion to develop and 
retain a gel form. It is the force, expressed in grams, necessary to depress by 4 mm the 
surface of a gel with a standard 0.5" diameter cylinder probe. During the test when a trigger 
force of 10 g is attained, the probe proceeds to penetrate the cream to a depth of 4 mm. 
During this penetration the force drops at the point where the cream breaks. After this the 
resulting forces are due to continuing penetration up to the required depth. The maximum 
positive force (i.e. the rupture point of the gel) is taken as an indication of rupture strength. 
The distance that the gel penetrates before this break occurs gives an indication of the gel's 
elasticity, i.e. a short distance of penetration before break indicates a brittle gel whereas a 
large distance of penetration before rupture indicates a more elastic gel.  A typical bloom 
strength evaluation plot of THC loaded cream is shown in figure . The rupture strength value 
of THC loaded cream is 51.197g. 
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Fig 39: Bloom Strength plot for THC Loaded Cream 
9.5.3. Extrudability Of Cream: 
The consistency of the cream was analysed by extruding it using an HDP/FE forward 
extrusion cell fitted to a Texture Analyser (Stable Micro Systems, Godalming, UK). This cell 
measures the compression force required for a piston to extrude a product through a standard 
size outlet in the base of the container. The sample container can accommodate base discs 
with outlet diameters of 3, 5, 7 or 10 mm. The selection of the base disc depends on the 
consistency of the sample. The compression-extrusion test consists of applying force on a 
cream until it flows through an outlet that may be in the form of an annulus (hole) present in 
the disc at the bottom of the test cell. The tightly fitted plunger acts almost like a piston 
compresses the sample and causes forward flow of the cream through the annulus of the disc. 
The cream is compressed until the structure of the cream is disrupted and starts extruding 
through the outlet. The pattern of forces involved in such a test is complex. Usually the 
maximum force required to accomplish extrusion is measured and used as an index of texture 
quality.  
The result in figure indicates that from 1 to 2 the sample is deformed and compressed 
to pack more and more tightly into the diminishing space available under the descending 
plunger; at this point there is little rupture of the sample. At approximately the point 2 the 
sample is packed solid and liquid may be expressed from it filling the interstices. At point 2 
or soon afterwards the pack is solid except for small amounts of entrapped air, and the force 
increases steeply from 2 pressing out more liquid or air in the process. After the point 2 the 
sample begins to rupture and flow through the annulus  (extrusion hole), and this process 
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continues to a point when the compressing plunger is reversed in direction and the force falls 
to zero. Point after 2 gives the force necessary to begin the process of extrusion, and the 
plateau shows the force needed to continue extrusion. It represents the increasing force being 
applied to an almost incompressible mixture of solids and liquid.The shape and magnitude of 
the compression-extrusion curve is influenced by the elasticity, viscoelasticity, viscosity, and 
rupture behaviour of the material; sample size, deformation rate, sample temperature, type of 
test cell; sample test size; and homogeneity of the sample. Preliminary tests showed that 
reproducible results of compression forces could be obtained using base discs with an outlet 
diameter of 3 mm. Lower amount of NLC in the cream gave very thick cream. The firmness 
of the cream in the study was 2112.834g. 
 
 
 
Fig 40: Extrudability of THC Loaded Cream 
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9.6. Stability studies 
Stability studies of the prepared Tetrahydrocurcumin loaded NLCs formulations and 
NLCs  Incorporated into cream was carried out for 3 months according to the ICH guidelines. 
The result showed that there were no significant changes in the cream. 
Table 21: Stability studies 
Formulation Code Particle Size (nm) 
1 Month 2 Month 3 Month 
TNC 4 (room temperature) 79.1 83.91 96.3 
TNC 4 (Refridgerator Condition) 55.1 52.2 51.9 
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10. SUMMARY AND CONCLUSION 
Generally, lipid based formulations often show poor stability due to microbial 
growth. The problem of bacterial resistance to conventional preservatives has been 
observed in recent years. In the current study, an attempt was made to enhance the 
stability of THC loaded lipid based formulations for nutricosmeceutical purpose using 
a natural preservation system.THC loaded nanostructured lipid carriers were prepared 
to serve as a carrier to enhance the bioavailability of  THC for nutraceutical purpose 
and lipid based cream loaded with NLCs of THC were prepared to serve as a carrier 
for the delivery of THC for cosmetic purpose. 
Initially, essential oils like cinnamon oil, peppermint oil, eucalyptus oil, 
lavender oil, clove oil, lemon grass oil, castor oil, neem oil and their mixtures were 
evaluated for antimicrobial activity. The results indicated a better antimicrobial 
property for cinnamon oil. Hence, THC loaded nanostructured lipid carriers and the 
corresponding creams were prepared using cinnamon oil as liquid oil carrier. THC 
loaded NLC were prepared from Cocoa butter, cinnamon oil and Soya lecithin by hot 
homogenization technique using ultra probe sonicator. The spherical shaped 
nanostructure lipid particles with a particle size of 55 nm showed a sustained release 
pattern across pig ear skin for around 96 % for 48 hours. The antimicrobial activity 
was studied by disc diffusion study, TNC 4 has good activity against gram positive 
(E.coli) and gram negative (S.aureus) bacterial strains  
These THC loaded nanostructure lipid particles were loaded in a lipid based 
cream (prepared from Cocoa butter, Cinnamon oil, Soya Lecithin). Evaluation of the 
texture properties of the lipid cream loaded with THC NLCs showed good firmness 
and stickiness. THC NLCs and lipid based cream loaded with THC NLCs showed 
good stability during the initial 3 months without any microbial contamination. Long 
term stability studies are in progress to evaluate the stability of the lipid based 
formulations for a period of 1 year. 
Lipid based nutricosmeceuticals prepared using cinnamon oil as a liquid oil 
can be a good promising natural preservative against microbial contamination and can 
possibly enhance the stability of several other lipid based nutricosmeceuticals loaded 
with different types of drugs.  
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